 01 Certain infectious or parasitic diseases
|
 Gastroenteritis or colitis of infectious origin
|
Predominantly sexually transmitted infections
|
Mycobacterial diseases
|
Certain staphylococcal or streptococcal diseases
|
Pyogenic bacterial infections of the skin or subcutaneous tissues
|
Certain zoonotic bacterial diseases
|
Other bacterial diseases
|
1C10 Actinomycosis
|
1C11 Bartonellosis
|
1C12 Whooping cough
|
 1C13 Tetanus
|
1C14 Obstetrical tetanus
|
1C15 Tetanus neonatorum
|
1C16 Gas gangrene
|
1C17 Diphtheria
|
1C18 Brazilian purpuric fever
|
1C19 Legionellosis
|
1C1A Listeriosis
|
1C1B Nocardiosis
|
1C1C Meningococcal disease
|
1C1D Yaws
|
1C1E Pinta
|
1C1F Endemic non-venereal syphilis
|
1C1G Lyme borreliosis
|
1C1H Necrotising ulcerative gingivitis
|
1C1J Relapsing fever
|
1C1J.0 Tick-borne relapsing fever
1C1J.1 Louse-borne relapsing fever
1C1J.Z Relapsing fever, unspecified
|
Other diseases due to chlamydiae
|
Rickettsioses
|
1C40 Campylobacteriosis
|
1C41 Bacterial infection of unspecified site
|
1C42 Melioidosis
|
1C43 Actinomycetoma
|
1C44 Non-pyogenic bacterial infections of the skin
|
1C45 Toxic shock syndrome
|
1C4Y Other specified bacterial diseases
|
1C4Z Unspecified bacterial disease
|
Human immunodeficiency virus disease
|
Viral infections of the central nervous system
|
Non-viral or unspecified infections of the central nervous system
|
Dengue
|
Certain arthropod-borne viral fevers
|
Certain zoonotic viral diseases
|
Certain other viral diseases
|
Influenza
|
Viral hepatitis
|
Viral infections characterised by skin or mucous membrane lesions
|
Mycoses
|
Parasitic diseases
|
Sepsis
|
1G60 Certain other disorders of infectious origin
|
Sequelae of infectious diseases
|
1H0Z Infection, unspecified
|
|
02 Neoplasms
|
Neoplasms of central nervous system or related structures
|
2A00 Primary neoplasms of brain
|
2A00.0 Gliomas of brain
|
2A00.00 Glioblastoma of brain
2A00.0Y Other specified gliomas of brain
2A00.0Z Gliomas of brain, unspecified
|
2A00.1 Embryonal tumours of brain
|
2A00.10 Medulloblastoma of brain
2A00.11 Central primitive neuroectodermal tumour
2A00.1Y Other specified embryonal tumours of brain
2A00.1Z Embryonal tumours of brain, unspecified
|
2A00.2 Tumours of neuroepithelial tissue of brain
|
2A00.20 Tumours of the pineal gland or pineal region
2A00.21 Mixed neuronal-glial tumours
2A00.22 Choroid plexus tumours
2A00.2Y Other specified tumours of neuroepithelial tissue of brain
2A00.2Z Tumours of neuroepithelial tissue of brain, unspecified
|
2A00.3 Central neurocytoma of brain
|
2A00.4 Astroblastoma of the brain
|
2A00.5 Primary neoplasm of brain of unknown or unspecified type
|
2A01 Primary neoplasms of meninges
|
2A01.0 Meningiomas
|
2A01.00 Primary malignant meningioma
2A01.0Y Other specified meningiomas
2A01.0Z Meningiomas, unspecified
|
2A01.1 Mesenchymal tumour of meninges
|
2A01.2 Primary neoplasm of meninges of unknown or unspecified type
|
2A02 Primary neoplasm of spinal cord, cranial nerves, paraspinal nerves or remaining parts of central nervous system
|
2A02.0 Gliomas of spinal cord, cranial or paraspinal nerves
|
2A02.00 Glioblastoma of spinal cord, cranial or paraspinal nerves
2A02.0Y Other specified gliomas of spinal cord, cranial or paraspinal nerves
2A02.0Z Gliomas of spinal cord, cranial or paraspinal nerves, unspecified
|
2A02.1 Tumours of cranial or paraspinal nerves
|
2A02.10 Malignant peripheral nerve sheath tumour of cranial or paraspinal nerves
2A02.11 Paraspinal neuroblastoma
2A02.12 Malignant neoplasm of the optic nerve
2A02.1Y Other specified tumours of cranial or paraspinal nerves
2A02.1Z Tumours of cranial or paraspinal nerves, unspecified
|
2A02.2 Primary neoplasm of spinal cord of unknown or unspecified type
|
2A02.3 Benign neoplasm of cranial nerves
|
2A02.4 Benign neoplasm of spinal cord
|
2A02.Z Primary neoplasm of spinal cord, cranial nerves, paraspinal nerves or remaining parts of central nervous system, unspecified
|
2A0Z Other and unspecified neoplasms of brain or central nervous system
|
Neoplasms of haematopoietic or lymphoid tissues
|
Myeloproliferative neoplasms
|
Myelodysplastic syndromes
|
Myelodysplastic and myeloproliferative neoplasms
|
Myeloid or lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1
|
2A60 Acute myeloid leukaemias and related precursor neoplasms
|
2A60.0 Acute myeloid leukaemia with recurrent genetic abnormalities
|
2A60.1 Acute myeloid leukaemia with myelodysplasia-related changes
|
2A60.2 Therapy-related myeloid neoplasms
|
2A60.20 Therapy related acute myeloid leukaemia or myelodysplastic syndrome
2A60.2Y Other specified therapy-related myeloid neoplasms
2A60.2Z Therapy-related myeloid neoplasms, unspecified
|
2A60.3 Acute myeloid leukaemia, not elsewhere classified by criteria of other types
|
2A60.4 Myeloid proliferation associated with Down syndrome
|
2A60.5 Blastic plasmacytoid dendritic cell neoplasm
|
2A60.Y Other specified acute myeloid leukaemias and related precursor neoplasms
|
2A60.Z Acute myeloid leukaemias and related precursor neoplasms, unspecified
|
2A61 Acute leukaemias of ambiguous lineage
|
Precursor lymphoid neoplasms
|
Mature B-cell neoplasms
|
Mature T-cell or NK-cell neoplasms
|
2B30 Hodgkin lymphoma
|
2B31 Histiocytic or dendritic cell neoplasms
|
2B32 Immunodeficiency-associated lymphoproliferative disorders
|
2B33 Malignant haematopoietic neoplasms without further specification
|
2B3Z Neoplasms of haematopoietic or lymphoid tissues, unspecified
|
Malignant neoplasms, except primary neoplasms of lymphoid, haematopoietic, central nervous system or related tissues
|
Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic, central nervous system or related tissues
|
Malignant mesenchymal neoplasms
|
Malignant neoplasms of lip, oral cavity or pharynx
|
Malignant neoplasms of digestive organs
|
Malignant neoplasms of middle ear, respiratory or intrathoracic organs
|
Malignant neoplasms of skin
|
Malignant neoplasms of peripheral nerves or autonomic nervous system
|
Malignant neoplasms of retroperitoneum, peritoneum or omentum
|
Malignant neoplasms of breast
|
Malignant neoplasms of female genital organs
|
Malignant neoplasms of male genital organs
|
Malignant neoplasms of urinary tract
|
Malignant neoplasms of eye or ocular adnexa
|
Malignant neoplasms of endocrine glands
|
2D10 Malignant neoplasms of thyroid gland
|
2D11 Malignant neoplasms of adrenal gland
|
2D12 Malignant neoplasms of other endocrine glands or related structures
|
2D12.0 Malignant epithelial neoplasms of other endocrine glands or related structures, unspecified type
2D12.1 Adenocarcinoma of other endocrine glands or related structures
2D12.Y Other specified malignant neoplasms of other endocrine glands or related structures
2D12.Z Malignant neoplasms of other endocrine glands or related structures, unspecified
|
2D1Z Malignant neoplasms of endocrine glands, unspecified
|
2D3Y Other specified malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic, central nervous system or related tissues
|
2D3Z Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic, central nervous system or related tissues, unspecified
|
Malignant neoplasms of ill-defined or unspecified primary sites
|
Malignant neoplasm metastases
|
In situ neoplasms, except of lymphoid, haematopoietic, central nervous system or related tissues
|
2E60 Carcinoma in situ of oral cavity, oesophagus or stomach
|
2E60.0 Carcinoma in situ of lip, oral cavity or pharynx
2E60.1 Carcinoma in situ of oesophagus
2E60.2 Carcinoma in situ of stomach
|
2E61 Carcinoma in situ of other or unspecified digestive organs
|
2E61.0 Carcinoma in situ of colon
2E61.1 Carcinoma in situ of rectum
2E61.2 Carcinoma in situ of anal canal
2E61.3 Carcinoma in situ of gallbladder, biliary tract or ampulla of Vater
2E61.Y Carcinoma in situ of other specified digestive organs
2E61.Z Carcinoma in situ of unspecified digestive organs
|
2E62 Carcinoma in situ of middle ear or respiratory system
|
2E62.0 Carcinoma in situ of larynx
2E62.1 Carcinoma in situ of trachea
2E62.2 Carcinoma in situ of bronchus or lung
2E62.Y Carcinoma in situ of other specified sites of middle ear or respiratory system
2E62.Z Carcinoma in situ of unspecified sites of middle ear or respiratory system
|
2E63 Melanoma in situ neoplasms
|
2E63.0 Melanoma in situ of skin
|
2E63.00 Lentigo maligna
2E63.0Z Melanoma in situ of skin, unspecified
|
2E63.1 Melanoma in situ of conjunctiva
|
2E63.Y Melanoma in situ neoplasms, other specified site
|
2E63.Z Melanoma in situ neoplasms, unspecified site
|
2E64 Carcinoma in situ of skin
|
2E64.0 Intraepidermal squamous cell carcinoma
|
2E64.00 Bowen disease of skin
2E64.01 Actinic intraepidermal squamous cell carcinoma
2E64.0Y Other specified intraepidermal squamous cell carcinoma
2E64.0Z Intraepidermal squamous cell carcinoma, unspecified
|
2E64.1 Extramammary Paget disease of skin
|
2E64.2 Carcinoma in situ of anal margin or perianal skin
|
2E64.Y Other specified carcinoma in situ of skin
|
2E64.Z Carcinoma in situ of skin, unspecified
|
2E65 Carcinoma in situ of breast
|
2E65.0 Lobular carcinoma in situ of breast
2E65.1 Lobular carcinoma in situ of breast, pleomorphic subtype
2E65.2 Ductal carcinoma in situ of breast
2E65.3 Ductal carcinoma in situ of breast, comedo subtype
2E65.4 Mixed ductal and lobular carcinoma in situ of breast
2E65.5 Paget disease of nipple
2E65.Y Other specified carcinoma in situ of breast
2E65.Z Carcinoma in situ of breast, unspecified
|
2E66 Carcinoma in situ of cervix uteri
|
2E66.2 High grade squamous intraepithelial lesion of cervix uteri
2E66.Y Other specified carcinoma in situ of cervix uteri
2E66.Z Carcinoma in situ of cervix uteri, unspecified
|
2E67 Carcinoma in situ of other or unspecified genital organs
|
2E67.0 Carcinoma in situ of endometrium
|
2E67.1 Carcinoma in situ of vulva
|
2E67.11 Vulvar Paget disease
2E67.12 Vulvar intraepithelial neoplasia, HPV-independent
2E67.13 High grade squamous intraepithelial lesion of vulva, HPV-associated
|
2E67.2 Carcinoma in situ of vagina
|
2E67.22 High grade squamous intraepithelial lesion of vagina
2E67.2Y Other specified carcinoma in situ of vagina
2E67.2Z Carcinoma in situ of vagina, unspecified
|
2E67.3 Carcinoma in situ of other or unspecified female genital organs
|
2E67.4 Carcinoma in situ of penis
|
2E67.40 Squamous cell carcinoma in situ of skin of penis
2E67.41 Squamous cell carcinoma in situ of mucocutaneous epithelium of penis
|
2E67.5 High grade intraepithelial lesion of prostate
|
2E67.6 Carcinoma in situ of other or unspecified male genital organs
|
2E68 Carcinoma in situ of bladder
|
2E69 Carcinoma in situ of other or unspecified urinary organs
|
2E6A Carcinoma in situ of the eye or ocular adnexa
|
2E6A.0 Carcinoma in situ of the conjunctiva
2E6A.1 Carcinoma in situ of the cornea
2E6A.Y Carcinoma in situ of other and unspecified part of the eye and adnexa
|
2E6B Carcinoma in situ of thyroid or other endocrine glands
|
2E6Y Carcinoma in situ of other specified site
|
2E6Z Carcinoma in situ of unspecified site
|
Benign neoplasms, except of lymphoid, haematopoietic, central nervous system or related tissues
|
Benign mesenchymal neoplasms
|
2E80 Benign lipomatous neoplasm
|
2E80.0 Lipoma
|
2E80.00 Superficial subcutaneous lipoma
2E80.01 Deep subfascial lipoma
2E80.02 Deep internal or visceral lipoma
2E80.0Y Lipoma, other specified site
2E80.0Z Lipoma, unspecified site
|
2E80.1 Lipoblastoma
|
2E80.Y Other specified benign lipomatous neoplasm
|
2E80.Z Benign lipomatous neoplasm, unspecified
|
2E81 Benign vascular neoplasms
|
2E81.0 Neoplastic haemangioma
|
2E81.00 Umbilical cord haemangioma
2E81.01 Conjunctival haemangioma or haemolymphangioma
2E81.0Y Neoplastic haemangioma of other specified site
2E81.0Z Neoplastic haemangioma, unspecified site
|
2E81.1 Benign lymphatic neoplasms
|
2E81.10 Disseminated lymphangiomatosis
2E81.11 Acquired progressive lymphangioma
2E81.1Y Other specified benign lymphatic neoplasms
2E81.1Z Benign lymphatic neoplasms, unspecified
|
2E81.2 Benign vascular neoplasms of infancy or childhood
|
2E81.20 Focal infantile haemangioma
2E81.21 Multifocal infantile haemangioma
2E81.2Y Other specified benign vascular neoplasms of infancy or childhood
2E81.2Z Benign vascular neoplasms of infancy or childhood, unspecified
|
2E81.Y Other specified benign vascular neoplasms
|
2E81.Z Benign vascular neoplasms, unspecified
|
2E82 Benign chondrogenic tumours
|
2E82.0 Benign chondrogenic tumours of bone or articular cartilage of limbs
2E82.1 Benign chondrogenic tumours of bone or articular cartilage of other specified sites
2E82.Z Benign chondrogenic tumours, site unspecified
|
2E83 Benign osteogenic tumours
|
2E83.0 Benign osteogenic tumours of bone or articular cartilage of skull or face
2E83.1 Benign osteogenic tumours of bone or articular cartilage of lower jaw
2E83.2 Benign osteogenic tumours of bone or articular cartilage of vertebral column
2E83.3 Benign osteogenic tumours of bone or articular cartilage of ribs, sternum or clavicle
2E83.4 Benign osteogenic tumours of bone or articular cartilage of pelvic bones, sacrum or coccyx
2E83.5 Benign osteogenic tumours of bone or articular cartilage of limbs
2E83.Y Benign osteogenic tumour of other specified site
2E83.Z Benign osteogenic tumour of unspecified site
|
2E84 Benign fibrogenic or myofibrogenic tumour
|
2E84.0 Benign fibrogenic or myofibrogenic tumour of skin
2E84.Y Benign fibrogenic or myofibrogenic tumour of other specified sites
2E84.Z Benign fibrogenic or myofibrogenic tumour, site unknown
|
2E85 Benign fibrohistiocytic tumour
|
2E85.0 Benign fibrohistiocytic tumour of soft tissues of limbs
2E85.1 Benign fibrohistiocytic tumour of retroperitoneum or peritoneum
2E85.2 Benign fibrohistiocytic tumour of skin
2E85.Y Benign fibrohistiocytic tumour of other specified sites
2E85.Z Benign fibrohistiocytic tumour, site unspecified
|
2E86 Benign smooth muscle or skeletal muscle tumour
|
2E86.0 Leiomyoma of uterus
2E86.1 Leiomyoma of other or unspecified sites
2E86.2 Rhabdomyoma
2E86.Y Other specified benign smooth muscle or skeletal muscle tumour
2E86.Z Benign smooth muscle or skeletal muscle tumour, unspecified
|
2E87 Benign gastrointestinal stromal tumour
|
2E88 Benign endometrial stromal nodule
|
2E89 Benign mesenchymal tumours of uncertain differentiation
|
2E89.0 Benign tumours of uncertain differentiation, bone or cartilage
|
2E89.1 Benign tumours of uncertain differentiation, soft tissue
|
2E89.10 Hepatic cystic hamartoma
2E89.1Y Other specified benign tumours of uncertain differentiation, soft tissue
2E89.1Z Benign tumours of uncertain differentiation, soft tissue, unspecified
|
2E89.Y Benign mesenchymal tumours of uncertain differentiation of other specified site
|
2E89.Z Benign mesenchymal tumours of uncertain differentiation of unspecified site
|
2E8A Other mixed benign mesenchymal tumours
|
2E8Y Other specified benign mesenchymal neoplasm
|
2E8Z Benign mesenchymal neoplasms, unspecified
|
Benign neoplasms except of mesenchymal origin
|
2E90 Benign neoplasm of lip, oral cavity or pharynx
|
2E90.0 Benign neoplasm of lip
2E90.1 Benign neoplasm of tongue
2E90.2 Benign neoplasm of floor of mouth
2E90.3 Benign neoplasm of other or unspecified parts of mouth
2E90.4 Benign neoplasm of tonsil
2E90.5 Benign neoplasm of oropharynx
2E90.6 Benign neoplasm of nasopharynx
2E90.7 Benign neoplasm of hypopharynx
2E90.8 Benign neoplasm of pharynx, unspecified
|
2E91 Benign neoplasm of major salivary glands
|
2E91.0 Benign neoplasm of parotid gland
2E91.1 Benign neoplasm of other specified major salivary glands
2E91.Z Benign neoplasm of unspecified major salivary glands
|
2E92 Benign neoplasm of digestive organs
|
2E92.0 Benign neoplasm of oesophagus
|
2E92.1 Benign neoplasm of stomach
|
2E92.2 Benign neoplasm of duodenum
|
2E92.3 Benign neoplasm of other or unspecified parts of small intestine
|
2E92.4 Benign neoplasm of the large intestine
|
2E92.40 Polyposis syndrome
2E92.4Y Other specified benign neoplasm of the large intestine
2E92.4Z Benign neoplasm of the large intestine, unspecified
|
2E92.5 Benign neoplasm of anus or anal canal
|
2E92.6 Benign neoplasm of gallbladder, extrahepatic bile ducts or ampulla of Vater
|
2E92.7 Benign neoplasm of liver or intrahepatic bile ducts
|
2E92.8 Benign neoplasm of pancreas
|
2E92.9 Benign neoplasm of endocrine pancreas
|
2E92.Y Benign neoplasm of other specified digestive organs
|
2E92.Z Benign neoplasm of unspecified digestive organs
|
Benign neoplasm of middle ear, respiratory or intrathoracic organs
|
2F00 Benign neoplasm of middle ear or respiratory system
|
2F00.0 Middle ear endocrine tumour
2F00.1 Recurrent respiratory papillomatosis
2F00.2 Laryngeal endocrine tumour
2F00.Y Other specified benign neoplasm of middle ear or respiratory system
2F00.Z Benign neoplasm of middle ear or respiratory system, unspecified
|
2F01 Benign neoplasm of other intrathoracic organs
|
2F10 Benign neoplasm of mesothelial tissue
|
Benign cutaneous neoplasms
|
2F20 Benign cutaneous melanocytic neoplasms
|
2F20.0 Common acquired melanocytic naevus
|
2F20.00 Multiple benign melanocytic naevi
2F20.0Y Other specified common acquired melanocytic naevus
2F20.0Z Common acquired melanocytic naevus, unspecified
|
2F20.1 Atypical melanocytic naevus
|
2F20.2 Congenital melanocytic naevus
|
2F20.20 Giant congenital melanocytic naevus
2F20.2Y Other specified congenital melanocytic naevus
2F20.2Z Congenital melanocytic naevus, unspecified
|
2F20.3 Generalised eruptive melanocytic naevi
|
2F20.Y Other specific types of melanocytic naevus
|
2F20.Z Melanocytic naevus, unspecified
|
2F21 Benign keratinocytic acanthomas
|
2F21.0 Seborrhoeic keratosis
2F21.Y Other specified benign keratinocytic acanthomas
|
2F22 Benign neoplasms of epidermal appendages
|
2F23 Benign dermal fibrous or fibrohistiocytic neoplasms
|
2F23.0 Dermatofibroma
2F23.Y Other specified benign dermal fibrous or fibrohistiocytic neoplasms
|
2F24 Benign cutaneous neoplasms of neural or nerve sheath origin
|
2F25 Cherry angioma
|
2F26 Lobular capillary haemangioma
|
2F2Y Other specified benign cutaneous neoplasms
|
2F2Z Benign cutaneous neoplasm of unspecified type
|
2F30 Benign neoplasm of breast
|
2F30.0 Tubular adenoma of breast
2F30.1 Lactating adenoma of breast
2F30.2 Intraductal papilloma of breast
2F30.3 Benign phyllodes tumour of breast
2F30.4 Fibromatosis of breast
2F30.5 Fibroadenoma of breast
2F30.6 Extensive adenomatosis of nipple
2F30.7 Benign neoplasm of the nipple
2F30.Y Other specified benign neoplasm of breast
2F30.Z Benign neoplasm of breast, unspecified
|
2F31 Benign non-mesenchymal neoplasms of uterus
|
2F31.0 Benign non-mesenchymal neoplasm of uterus, cervix uteri
2F31.1 Benign non-mesenchymal neoplasm of uterus, corpus uteri
2F31.2 Benign non-mesenchymal neoplasms of uterus, other parts
2F31.Z Benign non-mesenchymal neoplasms of uterus, unspecified
|
2F32 Benign neoplasm of ovary
|
2F32.0 Cystic teratoma
2F32.1 Ovarian fibroma
2F32.2 Meigs syndrome
2F32.3 Serous ovarian cystadenoma
2F32.Y Other specified benign neoplasm of ovary
2F32.Z Benign neoplasm of ovary, unspecified
|
2F33 Benign neoplasm of other or unspecified female genital organs
|
2F34 Benign neoplasm of male genital organs
|
2F35 Benign neoplasm of urinary organs
|
2F36 Benign neoplasm of eye or ocular adnexa
|
2F36.0 Benign neoplasm of choroid
2F36.1 Benign neoplasm of iris
2F36.2 Benign neoplasm of ciliary body
2F36.3 Teratoma of orbit
2F36.4 Cysts of eyelid
2F36.Y Benign neoplasm of eye or ocular adnexa, other specified site
2F36.Z Benign neoplasm of eye or ocular adnexa, unspecified site
|
2F37 Benign neoplasm of endocrine glands
|
2F37.0 Non-secreting pituitary adenoma
2F37.Y Other specified benign neoplasm of endocrine glands
2F37.Z Benign neoplasm of endocrine glands, unspecified
|
2F3Y Benign neoplasms except of mesenchymal origin, of other specified site
|
2F3Z Benign neoplasms except of mesenchymal origin, of unspecified site
|
Neoplasms of uncertain behaviour, except of lymphoid, haematopoietic, central nervous system or related tissues
|
2F70 Neoplasms of uncertain behaviour of oral cavity or digestive organs
|
2F70.0 Neoplasms of uncertain behaviour of lip, oral cavity or pharynx
2F70.1 Neoplasms of uncertain behaviour of stomach
2F70.2 Neoplasms of uncertain behaviour of small intestine
2F70.3 Neoplasms of uncertain behaviour of colon
2F70.4 Neoplasms of uncertain behaviour of rectum
2F70.5 Neoplasms of uncertain behaviour of liver, gallbladder or bile ducts
2F70.Y Neoplasms of uncertain behaviour of digestive organs, other specified site
2F70.Z Neoplasms of uncertain behaviour of digestive organs, unspecified site
|
2F71 Neoplasms of uncertain behaviour of middle ear, respiratory or intrathoracic organs
|
2F71.0 Neoplasms of uncertain behaviour of thymus
2F71.1 Neoplasms of uncertain behaviour of larynx
2F71.2 Neoplasms of uncertain behaviour of pleura
2F71.3 Neoplasms of uncertain behaviour of trachea, bronchus or lung
2F71.4 Neoplasms of uncertain behaviour of mediastinum
2F71.Y Neoplasms of uncertain behaviour of middle ear, respiratory or intrathoracic organs, other specified site
2F71.Z Neoplasms of uncertain behaviour of middle ear, respiratory or intrathoracic organs, unspecified site
|
2F72 Neoplasms of uncertain behaviour of skin
|
2F72.1 Spitzoid tumour of uncertain malignant potential
2F72.2 Melanocytic naevus with severe melanocytic dysplasia
2F72.Y Other specified neoplasms of uncertain behaviour of skin
|
2F73 Neoplasms of uncertain behaviour of retroperitoneum
|
2F74 Neoplasms of uncertain behaviour of peritoneum
|
2F75 Neoplasms of uncertain behaviour of breast
|
2F76 Neoplasms of uncertain behaviour of female genital organs
|
2F77 Neoplasms of uncertain behaviour of male genital organs
|
2F78 Neoplasms of uncertain behaviour of urinary organs
|
2F79 Neoplasms of uncertain behaviour of eye or ocular adnexa
|
2F7A Neoplasms of uncertain behaviour of endocrine glands
|
2F7A.0 Multiple polyglandular tumours
2F7A.Y Other specified neoplasms of uncertain behaviour of endocrine glands
2F7A.Z Neoplasms of uncertain behaviour of endocrine glands, unspecified
|
2F7B Neoplasms of uncertain behaviour of bone or articular cartilage
|
2F7C Neoplasms of uncertain behaviour of connective or other soft tissue
|
2F7Y Neoplasms of uncertain behaviour of other specified site
|
2F7Z Neoplasms of uncertain behaviour of unspecified site
|
Neoplasms of unknown behaviour, except of lymphoid, haematopoietic, central nervous system or related tissues
|
2F90 Neoplasms of unknown behaviour of oral cavity or digestive organs
|
2F90.0 Neoplasms of unknown behaviour of colon
2F90.1 Neoplasms of unknown behaviour of rectum
2F90.Y Neoplasms of unknown behaviour of oral cavity or digestive organs, other specified site
2F90.Z Neoplasms of unknown behaviour of oral cavity or digestive organs, unspecified site
|
2F91 Neoplasms of unknown behaviour of middle ear, respiratory or intrathoracic organs
|
2F91.0 Neoplasms of unknown behaviour of larynx
2F91.1 Neoplasms of unknown behaviour of trachea, bronchus or lung
2F91.Y Neoplasms of unknown behaviour of other specified respiratory organ, intrathoracic organ or middle ear
2F91.Z Neoplasms of unknown behaviour of unspecified respiratory organ or intrathoracic organ
|
2F92 Neoplasms of unknown behaviour of skin
|
2F93 Neoplasms of unknown behaviour of retroperitoneum
|
2F94 Neoplasms of unknown behaviour of peritoneum
|
2F95 Neoplasms of unknown behaviour of breast
|
2F96 Neoplasms of unknown behaviour of female genital organs
|
2F97 Neoplasms of unknown behaviour of male genital organs
|
2F98 Neoplasms of unknown behaviour of urinary organs
|
2F99 Neoplasms of unknown behaviour of eye or ocular adnexa
|
2F9A Neoplasms of unknown behaviour of endocrine glands
|
2F9B Neoplasms of unknown behaviour of bone or articular cartilage
|
2F9C Neoplasms of unknown behaviour of connective or other soft tissue
|
2F9Y Neoplasms of unknown behaviour of other specified site
|
2F9Z Neoplasms of unknown behaviour of unspecified site
|
|
03 Diseases of the blood or blood-forming organs
|
Anaemias or other erythrocyte disorders
|
Nutritional or metabolic anaemias
|
Haemolytic anaemias
|
3A50 Thalassaemias
|
3A50.0 Alpha thalassaemia
|
3A50.1 Alpha thalassaemia related syndromes
|
3A50.2 Beta thalassaemia
|
3A50.3 Delta, delta-beta or gamma-delta-beta thalassaemia
|
3A50.4 Hereditary persistence of fetal haemoglobin
|
3A50.Y Other specified thalassaemias
|
3A50.Z Thalassaemias, unspecified
|
3A51 Sickle cell disorders or other haemoglobinopathies
|
Pure red cell aplasia
|
3A70 Aplastic anaemia
|
3A71 Anaemia due to chronic disease
|
3A72 Sideroblastic anaemia
|
3A73 Congenital dyserythropoietic anaemia
|
Polycythaemia
|
3A80 Congenital polycythaemia
|
3A81 Acquired polycythaemia
|
3A81.0 Polycythaemia due to hypoxia, including high altitude
3A81.1 Polycythaemia due to over-transfusion or blood doping
3A81.2 Relative polycythaemia
3A81.Y Other specified acquired polycythaemia
3A81.Z Acquired polycythaemia, unspecified
|
3A8Z Polycythaemia, unspecified
|
3A90 Anaemia due to acute disease
|
3A91 Congenital methaemoglobinaemia
|
3A92 Hereditary methaemoglobinaemia
|
3A93 Acquired methaemoglobinaemia
|
3A94 Acute posthaemorrhagic anaemia
|
3A9Y Other specified anaemias or erythrocyte disorders
|
3A9Z Anaemias or other erythrocyte disorders, unspecified
|
Coagulation defects, purpura or other haemorrhagic or related conditions
|
Coagulation defects
|
Fibrinolytic defects
|
3B60 Non-thrombocytopenic purpura
|
3B61 Thrombophilia
|
3B62 Qualitative platelet defects
|
3B63 Thrombocytosis
|
3B64 Thrombocytopenia
|
3B65 Thrombotic microangiopathy, not elsewhere classified
|
3B6Y Other specified coagulation defects, purpura or other haemorrhagic or related conditions
|
3B6Z Coagulation defects, purpura or other haemorrhagic or related conditions, unspecified
|
Diseases of spleen
|
3C0Y Other specified diseases of the blood or blood-forming organs
|
3C0Z Diseases of the blood or blood-forming organs, unspecified
|
|
04 Diseases of the immune system
|
Primary immunodeficiencies
|
4A20 Acquired immunodeficiencies
|
Nonorgan specific systemic autoimmune disorders
|
4A40 Lupus erythematosus
|
4A41 Idiopathic inflammatory myopathy
|
4A42 Systemic sclerosis
|
4A43 Overlap or undifferentiated nonorgan specific systemic autoimmune disease
|
4A43.0 IgG4 related disease
|
4A43.1 Mikulicz disease
|
4A43.2 Sjögren syndrome
|
4A43.3 Mixed connective tissue disease
|
4A43.4 Diffuse eosinophilic fasciitis
|
4A43.Y Other specified overlap non-organ specific systemic autoimmune disease
|
4A43.Z Undifferentiated non-organ specific systemic autoimmune disease
|
4A44 Vasculitis
|
4A45 Antiphospholipid syndrome
|
4A4Y Other specified nonorgan specific systemic autoimmune disorders
|
4A4Z Nonorgan specific systemic autoimmune disorders, unspecified
|
Autoinflammatory disorders
|
Allergic or hypersensitivity conditions
|
Immune system disorders involving white cell lineages
|
Certain disorders involving the immune system
|
4B40 Diseases of thymus
|
4B4Y Other specified diseases of the immune system
|
4B4Z Diseases of the immune system, unspecified
|
|
05 Endocrine, nutritional or metabolic diseases
|
Endocrine diseases
|
Disorders of the thyroid gland or thyroid hormones system
|
5A00 Hypothyroidism
|
5A00.0 Congenital hypothyroidism
|
5A00.1 Iodine-deficiency-related thyroid disorders or allied conditions
|
5A00.10 Iodine-deficiency-related diffuse goitre
5A00.11 Iodine-deficiency-related multinodular goitre
5A00.1Z Iodine-deficiency-related thyroid disorders or allied conditions, unspecified
|
5A00.2 Acquired hypothyroidism
|
5A00.Z Hypothyroidism, unspecified
|
5A01 Nontoxic goitre
|
5A02 Thyrotoxicosis
|
5A03 Thyroiditis
|
5A04 Hypersecretion of calcitonin
|
5A05 Generalised resistance to thyroid hormone
|
5A06 Sick-euthyroid syndrome
|
5A0Y Other specified disorders of the thyroid gland or thyroid hormones system
|
5A0Z Disorders of the thyroid gland or thyroid hormones system, unspecified
|
Diabetes mellitus
|
5A10 Type 1 diabetes mellitus
|
5A11 Type 2 diabetes mellitus
|
5A12 Malnutrition-related diabetes mellitus
|
5A13 Diabetes mellitus, other specified type
|
5A14 Diabetes mellitus, type unspecified
|
Acute complications of diabetes mellitus
|
Other disorders of glucose regulation or pancreatic internal secretion
|
Disorders of the parathyroids or parathyroid hormone system
|
Disorders of the pituitary hormone system
|
Disorders of the adrenal glands or adrenal hormone system
|
Disorders of the gonadal hormone system
|
5A80 Ovarian dysfunction
|
5A81 Testicular dysfunction or testosterone-related disorders
|
5A81.0 Testicular hyperfunction
5A81.1 Testicular hypofunction
5A81.Y Other specified testicular dysfunction or testosterone-related disorders
5A81.Z Testicular dysfunction or testosterone-related disorders, unspecified
|
5A8Z Disorders of the gonadal hormone system, unspecified
|
Certain disorders of puberty
|
Polyglandular dysfunction
|
Endocrine disorders, not elsewhere classified
|
5B3Y Other specified endocrine diseases
|
5B3Z Endocrine diseases, unspecified
|
Nutritional disorders
|
Metabolic disorders
|
Postprocedural endocrine or metabolic disorders
|
|
06 Mental, behavioural or neurodevelopmental disorders
|
Neurodevelopmental disorders
|
Schizophrenia or other primary psychotic disorders
|
Catatonia
|
Mood disorders
|
Bipolar or related disorders
|
6A60 Bipolar type I disorder
|
6A61 Bipolar type II disorder
|
6A62 Cyclothymic disorder
|
6A6Y Other specified bipolar or related disorders
|
6A6Z Bipolar or related disorders, unspecified
|
Depressive disorders
|
6A80 Symptomatic and course presentations for mood episodes in mood disorders
|
6A8Y Other specified mood disorders
|
6A8Z Mood disorders, unspecified
|
Anxiety or fear-related disorders
|
6B00 Generalised anxiety disorder
6B01 Panic disorder
6B02 Agoraphobia
6B03 Specific phobia
6B04 Social anxiety disorder
6B05 Separation anxiety disorder
6B06 Selective mutism
6B0Y Other specified anxiety or fear-related disorders
6B0Z Anxiety or fear-related disorders, unspecified
|
Obsessive-compulsive or related disorders
|
6B20 Obsessive-compulsive disorder
|
6B21 Body dysmorphic disorder
|
6B22 Olfactory reference disorder
|
6B23 Hypochondriasis
|
6B24 Hoarding disorder
|
6B25 Body-focused repetitive behaviour disorders
|
6B2Y Other specified obsessive-compulsive or related disorders
|
6B2Z Obsessive-compulsive or related disorders, unspecified
|
Disorders specifically associated with stress
|
Dissociative disorders
|
Feeding or eating disorders
|
Elimination disorders
|
Disorders of bodily distress or bodily experience
|
Disorders due to substance use or addictive behaviours
|
Disorders due to substance use
|
6C40 Disorders due to use of alcohol
|
6C41 Disorders due to use of cannabis
|
6C42 Disorders due to use of synthetic cannabinoids
|
6C43 Disorders due to use of opioids
|
6C44 Disorders due to use of sedatives, hypnotics or anxiolytics
|
6C45 Disorders due to use of cocaine
|
6C45.0 Episode of harmful use of cocaine
|
6C45.1 Harmful pattern of use of cocaine
|
6C45.2 Cocaine dependence
|
6C45.3 Cocaine intoxication
|
6C45.4 Cocaine withdrawal
|
6C45.5 Cocaine-induced delirium
|
6C45.6 Cocaine-induced psychotic disorder
|
6C45.7 Certain specified cocaine-induced mental or behavioural disorders
|
6C45.70 Cocaine-induced mood disorder
6C45.71 Cocaine-induced anxiety disorder
6C45.72 Cocaine-induced obsessive-compulsive or related disorder
6C45.73 Cocaine-induced impulse control disorder
|
6C45.Y Other specified disorders due to use of cocaine
|
6C45.Z Disorders due to use of cocaine, unspecified
|
6C46 Disorders due to use of stimulants including amphetamines, methamphetamine or methcathinone
|
6C46.0 Episode of harmful use of stimulants including amphetamines, methamphetamine or methcathinone
|
6C46.1 Harmful pattern of use of stimulants including amphetamines, methamphetamine or methcathinone
|
6C46.2 Stimulant dependence including amphetamines, methamphetamine or methcathinone
|
6C46.3 Stimulant intoxication including amphetamines, methamphetamine or methcathinone
|
6C46.4 Stimulant withdrawal including amphetamines, methamphetamine or methcathinone
|
6C46.5 Stimulant-induced delirium including amphetamines, methamphetamine or methcathinone
|
6C46.6 Stimulant-induced psychotic disorder including amphetamines, methamphetamine or methcathinone
|
6C46.7 Certain specified stimulant-induced mental or behavioural disorders including amphetamines, methamphetamine or methcathinone
|
6C46.70 Stimulant-induced mood disorder including amphetamines, methamphetamine or methcathinone
6C46.71 Stimulant-induced anxiety disorder including amphetamines, methamphetamine or methcathinone
6C46.72 Stimulant-induced obsessive-compulsive or related disorder including amphetamines, methamphetamine or methcathinone
6C46.73 Stimulant-induced impulse control disorder including amphetamines, methamphetamine or methcathinone
|
6C46.Y Other specified disorders due to use of stimulants including amphetamines, methamphetamine or methcathinone
|
6C46.Z Disorders due to use of stimulants including amphetamines, methamphetamine or methcathinone, unspecified
|
6C47 Disorders due to use of synthetic cathinones
|
6C47.0 Episode of harmful use of synthetic cathinones
|
6C47.1 Harmful pattern of use of synthetic cathinones
|
6C47.2 Synthetic cathinone dependence
|
6C47.3 Synthetic cathinone intoxication
|
6C47.4 Synthetic cathinone withdrawal
|
6C47.5 Synthetic cathinone-induced delirium
|
6C47.6 Synthetic cathinone-induced psychotic disorder
|
6C47.7 Certain specified synthetic cathinone-induced mental or behavioural disorders
|
6C47.70 Synthetic cathinone-induced mood disorder
6C47.71 Synthetic cathinone-induced anxiety disorder
6C47.72 Synthetic cathinone-induced obsessive-compulsive or related syndrome
6C47.73 Synthetic cathinone-induced impulse control disorder
|
6C47.Y Other specified disorders due to use of synthetic cathinones
|
6C47.Z Disorders due to use of synthetic cathinones, unspecified
|
6C48 Disorders due to use of caffeine
|
6C49 Disorders due to use of hallucinogens
|
6C4A Disorders due to use of nicotine
|
6C4B Disorders due to use of volatile inhalants
|
6C4C Disorders due to use of methylene-dioxymethamphetamine [MDMA] or related drugs, including methylene-dioxyamphetamine [MDA]
|
6C4C.0 Episode of harmful use of MDMA or related drugs, including MDA
|
6C4C.1 Harmful pattern of use of MDMA or related drugs, including MDA
|
6C4C.10 Harmful use of MDMA or related drugs, including MDA, episodic
6C4C.11 Harmful use of MDMA or related drugs, including MDA, continuous
6C4C.1Z Harmful pattern of use of MDMA or related drugs, including MDA, unspecified
|
6C4C.2 MDMA or related drug dependence, including MDA
|
6C4C.20 MDMA or related drug dependence, including MDA, current use
6C4C.21 MDMA or related drug dependence, including MDA, early full remission
6C4C.22 MDMA or related drug dependence, including MDA, sustained partial remission
6C4C.23 MDMA or related drug dependence, including MDA, sustained full remission
6C4C.2Z MDMA or related drug dependence, including MDA, unspecified
|
6C4C.3 MDMA or related drug intoxication, including MDA
|
6C4C.4 MDMA or related drug withdrawal, including MDA
|
6C4C.5 MDMA or related drug-induced delirium, including MDA
|
6C4C.6 MDMA or related drug-induced psychotic disorder, including MDA
|
6C4C.7 Certain specified MDMA or related drug-induced mental or behavioural disorders, including MDA
|
6C4C.70 MDMA or related drug-induced mood disorder, including MDA
6C4C.71 MDMA or related drug-induced anxiety disorder
|
6C4C.Y Other specified disorders due to use of methylene-dioxymethamphetamine [MDMA] or related drugs, including methylene-dioxyamphetamine [MDA]
|
6C4C.Z Disorders due to use of methylene-dioxymethamphetamine [MDMA] or related drugs, including methylene-dioxyamphetamine [MDA], unspecified
|
6C4D Disorders due to use of dissociative drugs including ketamine or phencyclidine (PCP)
|
6C4E Disorders due to use of other specified psychoactive substances, including medications
|
6C4E.0 Episode of harmful use of other specified psychoactive substance
|
6C4E.1 Harmful pattern of use of other specified psychoactive substance
|
6C4E.2 Other specified psychoactive substance dependence
|
6C4E.3 Other specified psychoactive substance intoxication
|
6C4E.4 Other specified psychoactive substance withdrawal
|
6C4E.5 Delirium induced by other specified psychoactive substance including medications
|
6C4E.6 Psychotic disorder induced by other specified psychoactive substance
|
6C4E.7 Certain other specified psychoactive substance-induced mental or behavioural disorders
|
6C4E.70 Mood disorder induced by other specified psychoactive substance
6C4E.71 Anxiety disorder induced by other specified psychoactive substance
6C4E.72 Obsessive-compulsive or related disorder induced by other specified psychoactive substance
6C4E.73 Impulse control disorder induced by other specified psychoactive substance
|
6C4E.Y Other specified disorders due to use of other specified psychoactive substances, including medications
|
6C4E.Z Disorders due to use of other specified psychoactive substances, including medications, unspecified
|
6C4F Disorders due to use of multiple specified psychoactive substances, including medications
|
6C4F.0 Episode of harmful use of multiple specified psychoactive substances
|
6C4F.1 Harmful pattern of use of multiple specified psychoactive substances
|
6C4F.2 Multiple specified psychoactive substances dependence
|
6C4F.3 Intoxication due to multiple specified psychoactive substances
|
6C4F.4 Multiple specified psychoactive substances withdrawal
|
6C4F.5 Delirium induced by multiple specified psychoactive substances including medications
|
6C4F.6 Psychotic disorder induced by multiple specified psychoactive substances
|
6C4F.7 Certain multiple specified psychoactive substances-induced mental or behavioural disorders
|
6C4F.70 Mood disorder induced by multiple specified psychoactive substances
6C4F.71 Anxiety disorder induced by multiple specified psychoactive substances
6C4F.72 Obsessive-compulsive or related disorder induced by multiple specified psychoactive substances
6C4F.73 Impulse control disorder induced by multiple specified psychoactive substances
|
6C4F.Y Other specified disorders due to use of multiple specified psychoactive substances, including medications
|
6C4F.Z Disorders due to use of multiple specified psychoactive substances, including medications, unspecified
|
6C4G Disorders due to use of unknown or unspecified psychoactive substances
|
6C4G.0 Episode of harmful use of unknown or unspecified psychoactive substances
|
6C4G.1 Harmful pattern of use of unknown or unspecified psychoactive substance
|
6C4G.2 Unknown or unspecified psychoactive substance dependence
|
6C4G.3 Intoxication due to unknown or unspecified psychoactive substance
|
6C4G.4 Withdrawal due to unknown or unspecified psychoactive substance
|
6C4G.5 Delirium induced by unknown or unspecified psychoactive substance
|
6C4G.6 Psychotic disorder induced by unknown or unspecified psychoactive substance
|
6C4G.7 Certain unknown or unspecified psychoactive substance-induced mental or behavioural disorders
|
6C4G.70 Mood disorder induced by unknown or unspecified psychoactive substance
6C4G.71 Anxiety disorder induced by unknown or unspecified psychoactive substance
6C4G.72 Obsessive-compulsive or related disorder induced by unknown or unspecified psychoactive substance
6C4G.73 Impulse control disorder induced by unknown or unspecified psychoactive substance
|
6C4G.Y Other specified disorders due to use of unknown or unspecified psychoactive substances
|
6C4G.Z Disorders due to use of unknown or unspecified psychoactive substances, unspecified
|
6C4H Disorders due to use of non-psychoactive substances
|
6C4Y Other specified disorders due to substance use
|
6C4Z Disorders due to substance use, unspecified
|
Disorders due to addictive behaviours
|
Impulse control disorders
|
Disruptive behaviour or dissocial disorders
|
Personality disorders and related traits
|
6D10 Personality disorder
|
6D10.0 Mild personality disorder
6D10.1 Moderate personality disorder
6D10.2 Severe personality disorder
6D10.Z Personality disorder, severity unspecified
|
6D11 Prominent personality traits or patterns
|
6D11.0 Negative affectivity in personality disorder or personality difficulty
6D11.1 Detachment in personality disorder or personality difficulty
6D11.2 Dissociality in personality disorder or personality difficulty
6D11.3 Disinhibition in personality disorder or personality difficulty
6D11.4 Anankastia in personality disorder or personality difficulty
6D11.5 Borderline pattern
|
Paraphilic disorders
|
Factitious disorders
|
Neurocognitive disorders
|
Mental or behavioural disorders associated with pregnancy, childbirth or the puerperium
|
6E40 Psychological or behavioural factors affecting disorders or diseases classified elsewhere
|
6E40.0 Mental disorder affecting disorders or diseases classified elsewhere
6E40.1 Psychological symptoms affecting disorders or diseases classified elsewhere
6E40.2 Personality traits or coping style affecting disorders or diseases classified elsewhere
6E40.3 Maladaptive health behaviours affecting disorders or diseases classified elsewhere
6E40.4 Stress-related physiological response affecting disorders or diseases classified elsewhere
6E40.Y Other specified psychological or behavioural factors affecting disorders or diseases classified elsewhere
6E40.Z Psychological or behavioural factors affecting disorders or diseases classified elsewhere, unspecified
|
Secondary mental or behavioural syndromes associated with disorders or diseases classified elsewhere
|
6E60 Secondary neurodevelopmental syndrome
|
6E61 Secondary psychotic syndrome
|
6E62 Secondary mood syndrome
|
6E63 Secondary anxiety syndrome
|
6E64 Secondary obsessive-compulsive or related syndrome
|
6E65 Secondary dissociative syndrome
|
6E66 Secondary impulse control syndrome
|
6E67 Secondary neurocognitive syndrome
|
6E68 Secondary personality change
|
6E69 Secondary catatonia syndrome
|
6E6Y Other specified secondary mental or behavioural syndrome
|
6E6Z Secondary mental or behavioural syndrome, unspecified
|
6E8Y Other specified mental, behavioural or neurodevelopmental disorders
|
6E8Z Mental, behavioural or neurodevelopmental disorders, unspecified
|
|
07 Sleep-wake disorders
|
Insomnia disorders
|
Hypersomnolence disorders
|
Sleep-related breathing disorders
|
7A40 Central sleep apnoeas
|
7A41 Obstructive sleep apnoea
|
7A42 Sleep-related hypoventilation or hypoxemia disorders
|
7A42.0 Obesity hypoventilation syndrome
7A42.1 Congenital central alveolar sleep-related hypoventilation
7A42.2 Non-congenital central hypoventilation with hypothalamic abnormalities
7A42.3 Idiopathic central alveolar hypoventilation
7A42.4 Sleep-related hypoventilation due to a medication or substance
7A42.5 Sleep-related hypoventilation due to medical condition
7A42.6 Sleep-related hypoxemia due to a medical condition
7A42.Y Other specified sleep-related hypoventilation or hypoxemia disorders
7A42.Z Sleep-related hypoventilation or hypoxemia disorders, unspecified
|
7A4Y Other specified sleep-related breathing disorders
|
7A4Z Sleep-related breathing disorders, unspecified
|
Circadian rhythm sleep-wake disorders
|
Sleep-related movement disorders
|
7A80 Restless legs syndrome
7A81 Periodic limb movement disorder
7A82 Sleep-related leg cramps
7A83 Sleep-related bruxism
7A84 Sleep-related rhythmic movement disorder
7A85 Benign sleep myoclonus of infancy
7A86 Propriospinal myoclonus at sleep onset
7A87 Sleep-related movement disorder due to a medical condition
7A88 Sleep-related movement disorder due to a medication or substance
7A8Y Other specified sleep-related movement disorders
7A8Z Sleep-related movement disorders, unspecified
|
Parasomnia disorders
|
7B00 Disorders of arousal from non-REM sleep
|
7B00.0 Confusional arousals
7B00.1 Sleepwalking disorder
7B00.2 Sleep terrors
7B00.3 Sleep-related eating disorder
7B00.Y Other specified disorders of arousal from non-REM sleep
7B00.Z Disorders of arousal from non-REM sleep, unspecified
|
7B01 Parasomnias related to REM sleep
|
7B01.0 REM sleep behaviour disorder
7B01.1 Recurrent isolated sleep paralysis
7B01.2 Nightmare disorder
7B01.Y Other specified parasomnias related to REM sleep
7B01.Z Parasomnias related to REM sleep, unspecified
|
7B02 Other parasomnias
|
7B02.0 Hypnagogic exploding head syndrome
7B02.1 Sleep-related hallucinations
7B02.2 Parasomnia disorder due to a medical condition
7B02.3 Parasomnia disorder due to a medication or substance
|
7B0Y Other specified parasomnia disorders
|
7B0Z Parasomnia disorders, unspecified
|
7B2Y Other specified sleep-wake disorders
|
7B2Z Sleep-wake disorders, unspecified
|
|
08 Diseases of the nervous system
|
Movement disorders
|
8A00 Parkinsonism
|
8A01 Choreiform disorders
|
8A02 Dystonic disorders
|
8A03 Ataxic disorders
|
8A04 Disorders associated with tremor
|
8A04.0 Enhanced physiological tremor
|
8A04.1 Essential tremor or related tremors
|
8A04.2 Rest tremor
|
8A04.3 Secondary tremor
|
8A04.4 Functional tremor
|
8A04.Y Other specified disorders associated with tremor
|
8A04.Z Disorders associated with tremor, unspecified
|
8A05 Tic disorders
|
8A06 Myoclonic disorders
|
8A07 Certain specified movement disorder
|
8A0Y Other specified movement disorders
|
8A0Z Movement disorders, unspecified
|
Disorders with neurocognitive impairment as a major feature
|
Multiple sclerosis or other white matter disorders
|
8A40 Multiple sclerosis
|
8A40.0 Relapsing-remitting multiple sclerosis
8A40.1 Primary progressive multiple sclerosis
8A40.2 Secondary progressive multiple sclerosis
8A40.Y Other specified multiple sclerosis
8A40.Z Multiple sclerosis, unspecified
|
8A41 Isolated demyelinating syndromes of the central nervous system
|
8A42 Acute disseminated encephalomyelitis
|
8A43 Neuromyelitis optica
|
8A44 Leukodystrophies
|
8A45 Secondary white matter disorders
|
8A46 Central demyelination of corpus callosum
|
8A4Y Other specified multiple sclerosis or other white matter disorders
|
8A4Z Multiple sclerosis or other white matter disorders, unspecified
|
Epilepsy or seizures
|
Headache disorders
|
8A80 Migraine
|
8A80.0 Migraine without aura
|
8A80.1 Migraine with aura
|
8A80.2 Chronic migraine
|
8A80.3 Complications related to migraine
|
8A80.30 Status migrainosus
8A80.3Y Other specified complications related to migraine
8A80.3Z Complications related to migraine, unspecified
|
8A80.4 Cyclic vomiting syndrome
|
8A80.Y Other specified migraine
|
8A80.Z Migraine, unspecified
|
8A81 Tension-type headache
|
8A82 Trigeminal autonomic cephalalgias
|
8A83 Other primary headache disorder
|
8A84 Secondary headache
|
8A85 Painful cranial neuropathies or other facial pains
|
8A8Y Other specified headache disorders
|
8A8Z Headache disorders, unspecified
|
Cerebrovascular diseases
|
Spinal cord disorders excluding trauma
|
Motor neuron diseases or related disorders
|
8B60 Motor neuron disease
|
8B61 Spinal muscular atrophy
|
8B62 Post polio progressive muscular atrophy
|
8B6Y Other specified motor neuron diseases or related disorders
|
8B6Z Motor neuron diseases or related disorders, unspecified
|
Disorders of nerve root, plexus or peripheral nerves
|
Diseases of neuromuscular junction or muscle
|
Cerebral palsy
|
Nutritional or toxic disorders of the nervous system
|
8D40 Neurological disorders due to nutrient deficiency
|
8D41 Neurological disorders due to an excess of micro or macro nutrients
|
8D41.0 Peripheral neuropathy due to vitamin B6 hyperalimentation
8D41.1 Myopathy due to hypercalcaemia
8D41.2 Pseudotumour Cerebri related to Hypervitaminosis A
8D41.Y Other specified neurological disorders due to an excess of micro or macro nutrients
8D41.Z Neurological disorders due to an excess of micro or macro nutrients, unspecified
|
8D42 Neurological disorders due to overweight or obesity in adults or children
|
8D43 Neurological disorders due to toxicity
|
8D44 Alcohol-related neurological disorders
|
8D44.0 Alcoholic polyneuropathy
8D44.1 Alcoholic myopathy
8D44.Y Other specified alcohol-related neurological disorders
8D44.Z Alcohol-related neurological disorders, unspecified
|
8D4Y Other specified nutritional or toxic disorders of the nervous system
|
8D4Z Nutritional or toxic disorders of the nervous system, unspecified
|
Disorders of cerebrospinal fluid pressure or flow
|
Disorders of autonomic nervous system
|
Human prion diseases
|
Disorders of consciousness
|
Certain disorders of the nervous system
|
Postprocedural disorders of the nervous system
|
8E7Y Other specified diseases of the nervous system
|
8E7Z Diseases of the nervous system, unspecified
|
|
09 Diseases of the visual system
|
Disorders of the ocular adnexa or orbit
|
Disorders of the eyeball anterior segment
|
Disorders of conjunctiva
|
Disorders of the cornea
|
Disorders of the anterior chamber
|
Disorders of the anterior uvea
|
Functional disorders of the pupil
|
9B00 Disorders of the afferent pupillary system
|
9B00.0 Relative afferent pupillary defects
9B00.1 Amaurotic pupillary reaction
9B00.2 Paradoxical pupillary reaction to light or darkness
9B00.3 Wernicke pupils
9B00.Y Other specified disorders of the afferent pupillary system
9B00.Z Disorders of the afferent pupillary system, unspecified
|
9B01 Disorders of the efferent pupillary system
|
9B02 Light-near dissociations
|
9B0Y Other specified functional disorders of the pupil
|
9B0Z Functional disorders of the pupil, unspecified
|
Disorders of lens
|
9B10 Cataract
|
9B10.0 Age-related cataract
|
9B10.00 Coronary age-related cataract
9B10.01 Punctate age-related cataract
9B10.02 Mature age-related cataract
9B10.0Y Other specified age-related cataract
9B10.0Z Age-related cataract, unspecified
|
9B10.1 Infantile or juvenile cataract
|
9B10.2 Certain specified cataracts
|
9B10.Z Cataract, unspecified
|
9B11 Certain specified disorders of lens
|
9B1Z Disorders of lens, unspecified
|
9B3Y Other specified disorders of the eyeball anterior segment
|
9B3Z Disorders of the eyeball anterior segment, unspecified
|
Disorders of the eyeball posterior segment
|
Disorders of sclera
|
Disorders of the choroid
|
Disorders of the retina
|
9B70 Inherited retinal dystrophies
|
9B71 Retinopathy
|
9B72 Inflammatory diseases of the retina
|
9B73 Retinal detachments or breaks
|
9B74 Retinal vascular occlusions
|
9B75 Macular disorders
|
9B75.0 Age-related macular degeneration
|
9B75.00 Early age-related macular degeneration
9B75.01 Intermediate age-related macular degeneration
9B75.03 Atrophic late-stage age-related macular degeneration
9B75.04 Neovascular late-stage age-related macular degeneration
9B75.0Y Other specified age-related macular degeneration
9B75.0Z Age-related macular degeneration, unspecified
|
9B75.1 Non-traumatic macular hole
|
9B75.2 Central serous chorioretinopathy
|
9B75.3 Macular telangiectasia
|
9B75.Y Other specified macular disorders
|
9B75.Z Macular disorders, unspecified
|
9B76 Degenerative high myopia
|
9B77 Eales disease
|
9B78 Certain specified retinal disorders
|
9B7Y Other specified disorders of the retina
|
9B7Z Disorders of the retina, unspecified
|
Disorders of the vitreous body
|
9C0Y Other specified disorders of the eyeball posterior segment
|
9C0Z Disorders of the eyeball posterior segment, unspecified
|
Disorders of the eyeball affecting both anterior and posterior segments
|
Disorders of the visual pathways or centres
|
Glaucoma or glaucoma suspect
|
Strabismus or ocular motility disorders
|
Disorders of refraction or accommodation
|
Postprocedural disorders of eye or ocular adnexa
|
Impairment of visual functions
|
Vision impairment
|
9D90 Vision impairment including blindness
|
9D92 Specific vision dysfunctions
|
9D93 Complex vision-related dysfunctions
|
9D94 Impairment of presenting visual acuity
|
9D95 Impairment of best corrected visual acuity
|
9D96 Impairment of uncorrected visual acuity
|
9D9Y Other specified vision impairment
|
9D9Z Vision impairment, unspecified
|
9E1Y Other specified diseases of the visual system
|
9E1Z Diseases of the visual system, unspecified
|
|
10 Diseases of the ear or mastoid process
|
Diseases of external ear
|
Diseases of middle ear or mastoid
|
Otitis media
|
AB10 Disorders of Eustachian tube
|
AB11 Mastoiditis or related conditions
|
AB11.0 Acute mastoiditis
AB11.1 Chronic mastoiditis
AB11.2 Petrositis
AB11.3 Mastoiditis, unspecified as acute or chronic
AB11.Y Other specified mastoiditis related conditions
|
AB12 Cholesteatoma of middle ear
|
AB13 Perforation of tympanic membrane
|
AB14 Acute myringitis
|
AB15 Chronic myringitis
|
AB16 Tympanosclerosis
|
AB17 Adhesive middle ear disease
|
AB18 Discontinuity or dislocation of ear ossicles
|
AB19 Acquired abnormalities of ear ossicles not related to discontinuity or dislocation
|
AB1A Polyp of middle ear
|
AB1B Middle ear cicatrix
|
AB1Y Other specified diseases of middle ear or mastoid
|
AB1Z Diseases of middle ear or mastoid, unspecified
|
Diseases of inner ear
|
Disorders with hearing impairment
|
Disorders of ear, not elsewhere classified
|
Postprocedural disorders of ear or mastoid process
|
AC0Y Other specified diseases of the ear or mastoid process
|
AC0Z Diseases of the ear or mastoid process, unspecified
|
|
11 Diseases of the circulatory system
|
Hypertensive diseases
|
Hypotension
|
Ischaemic heart diseases
|
Acute ischaemic heart disease
|
Chronic ischaemic heart disease
|
BA60 Certain current complications following acute myocardial infarction
|
BA60.0 Dressler syndrome
BA60.1 Other pericarditis as current complication following acute myocardial infarction
BA60.2 Ventricular aneurysm as current complication following acute myocardial infarction
BA60.3 Ventricular septal defect as current complication following acute myocardial infarction
BA60.4 Cardiac rupture as current complication following acute myocardial infarction
BA60.5 Pulmonary embolism as current complication following acute myocardial infarction
BA60.6 Rupture of papillary muscle or chordae tendineae as current complication following acute myocardial infarction
BA60.7 Mural thrombus as current complication following acute myocardial infarction
BA60.8 Arrhythmia as current complication following acute myocardial infarction
BA60.9 Cardiogenic shock, unrelated to mechanical complications, as current complication following acute myocardial infarction
BA60.Y Other specified current complications following acute myocardial infarction
BA60.Z Certain current complications following acute myocardial infarction, unspecified
|
BA6Z Ischaemic heart diseases, unspecified
|
Diseases of coronary artery
|
Pulmonary heart disease or diseases of pulmonary circulation
|
Pericarditis
|
Acute or subacute endocarditis
|
Heart valve diseases
|
BC20 Chronic rheumatic heart diseases, not elsewhere classified
|
Diseases of the myocardium or cardiac chambers
|
Cardiac arrhythmia
|
Heart failure
|
Diseases of arteries or arterioles
|
BD30 Acute arterial occlusion
|
Chronic arterial occlusive disease
|
BD50 Aortic aneurysm or dissection
|
BD51 Arterial aneurysm or dissection, excluding aorta
|
BD52 Certain specified disorders of arteries or arterioles
|
BD52.0 Segmental arterial mediolysis
|
BD52.1 Arteriovenous fistula, acquired
|
BD52.2 Stricture of artery
|
BD52.3 Rupture of artery
|
BD52.4 Necrosis of artery
|
BD52.5 Coeliac artery compression syndrome
|
BD52.6 Congenital great vessel related acquired abnormality
|
BD52.7 Certain acquired abnormalities of aorta
|
BD53 Secondary disorders of arteries or arterioles
|
BD54 Diabetic foot ulcer
|
BD55 Asymptomatic stenosis of intracranial or extracranial artery
|
BD56 Asymptomatic occlusion of intracranial or extracranial artery
|
BD5Y Other specified diseases of arteries or arterioles
|
BD5Z Diseases of arteries or arterioles, unspecified
|
Diseases of veins
|
Disorders of lymphatic vessels or lymph nodes
|
Postprocedural disorders of circulatory system
|
BE10 Postcardiotomy syndrome
|
BE11 Other functional disturbances following cardiac surgery
|
BE12 Postprocedural valve disorders
|
BE13 Postprocedural true or false aortic aneurysm
|
BE14 Postprocedural disorder of circulatory system following repair of congenital heart or great vessel anomaly
|
BE14.4 Acquired abnormality of the neopulmonary valve
|
BE14.5 Postprocedural right-sided atrioventricular valvar abnormality in double-inlet ventricle
|
BE14.6 Postprocedural left-sided atrioventricular valvar abnormality in double-inlet ventricle
|
BE14.7 Postprocedural common atrioventricular valvar abnormality in double-inlet ventricle
|
BE14.8 Postprocedural ventricular septal defect disorder
|
BE14.9 Postprocedural aortic disorder related to congenital heart anomaly
|
BE14.A Postprocedural arterial duct disorder
|
BE14.B Postprocedural disorder following cardiovascular conduit or shunt procedure
|
BE15 Postprocedural pulmonary arterial tree disorder
|
BE16 Postprocedural pulmonary venous disorder
|
BE17 Postprocedural residual or recurrent interatrial communication
|
BE19 Postprocedural ventricular abnormality
|
BE1A Cardiac transplant associated coronary allograft vasculopathy
|
BE1B Lymphoedema due to surgery or radiotherapy
|
BE1C Inferior caval vein obstruction due to foreign body
|
BE1D Superior caval vein obstruction due to foreign body
|
BE1E Postprocedural right atrial complication
|
BE1F Postprocedural left atrial complication
|
BE20 Embolism, so stated
|
BE21 Thromboembolism, so stated
|
BE2Y Other specified diseases of the circulatory system
|
BE2Z Diseases of the circulatory system, unspecified
|
|
12 Diseases of the respiratory system
|
Upper respiratory tract disorders
|
Certain lower respiratory tract diseases
|
Lung infections
|
Lung diseases due to external agents
|
Respiratory diseases principally affecting the lung interstitium
|
Pleural, diaphragm or mediastinal disorders
|
CB40 Certain diseases of the respiratory system
|
CB41 Respiratory failure
|
Postprocedural disorders of the respiratory system
|
CB60 Tracheostomy malfunction
CB61 Chronic pulmonary insufficiency following surgery
CB62 Postprocedural subglottic stenosis
CB63 Postprocedural stenosis of the trachea
CB64 Transfusion related acute lung injury
|
CB7Z Diseases of the respiratory system, unspecified
|
|
13 Diseases of the digestive system
|
Diseases or disorders of orofacial complex
|
DA00 Disorders of lips
|
DA01 Disorders of oral mucosa
|
DA02 Miscellaneous specified disorders of lips or oral mucosa
|
DA03 Diseases of tongue
|
DA04 Diseases of salivary glands
|
DA05 Cysts of oral or facial-neck region
|
DA06 Diseases of jaws
|
DA07 Disorders of tooth development or eruption
|
DA07.0 Fluoride related opacities or lesions
|
DA07.1 Nonfluoride enamel opacities
|
DA07.3 Disturbances in tooth formation
|
DA07.4 Root anomaly
|
DA07.5 Cementum dysplasia
|
DA07.6 Disturbances in tooth eruption
|
DA07.7 Embedded teeth
|
DA07.8 Impacted teeth
|
DA07.Y Other specified disorders of tooth development or eruption
|
DA07.Z Disorders of tooth development or eruption, unspecified
|
DA08 Diseases of hard tissues of teeth
|
DA09 Diseases of pulp or periapical tissues
|
DA0A Certain specified disorders of teeth or supporting structures
|
DA0B Gingival diseases
|
DA0C Periodontal disease
|
DA0D Certain specified disorders of gingiva or edentulous alveolar ridge
|
DA0E Dentofacial anomalies
|
DA0E.0 Major anomalies of jaw size
|
DA0E.1 Anomalies of jaw-cranial base relationship
|
DA0E.2 Anomalies of dental arch relationship
|
DA0E.3 Anomalies of tooth position
|
DA0E.4 Food impaction
|
DA0E.5 Malocclusion
|
DA0E.6 Dentofacial functional abnormalities
|
DA0E.7 Dentofacial parafunctional disorders
|
DA0E.8 Temporomandibular joint disorders
|
DA0E.Y Other specified dentofacial anomalies
|
DA0E.Z Dentofacial anomalies, unspecified
|
DA0F Sensory disturbances affecting orofacial complex
|
DA0Y Other specified diseases or disorders of orofacial complex
|
DA0Z Diseases or disorders of orofacial complex, unspecified
|
Diseases of oesophagus
|
Diseases of the stomach or the duodenum
|
Diseases of small intestine
|
Diseases of appendix
|
Diseases of large intestine
|
Diseases of anal canal
|
Diseases of liver
|
Diseases of gallbladder or biliary tract
|
Diseases of pancreas
|
Diseases of peritoneum
|
Diverticular disease of intestine
|
Ischaemic vascular disorders of intestine
|
Hernias
|
Inflammatory bowel diseases
|
Functional gastrointestinal disorders
|
Postprocedural disorders of digestive system
|
DE2Y Other specified diseases of the digestive system
|
DE2Z Diseases of the digestive system, unspecified
|
|
14 Diseases of the skin
|
Certain skin disorders attributable to infection or infestation
|
Inflammatory dermatoses
|
Dermatitis or eczema
|
EA80 Atopic eczema
|
EA81 Seborrhoeic dermatitis and related conditions
|
EA81.0 Seborrhoeic dermatitis of face
EA81.1 Seborrhoeic dermatitis of the scalp
EA81.Y Seborrhoeic dermatosis of other specified type or distribution
EA81.Z Seborrhoeic dermatitis, unspecified
|
EA82 Nummular dermatitis
|
EA83 Lichen simplex or lichenification
|
EA84 Asteatotic eczema
|
EA85 Dermatitis or eczema of hands or feet
|
EA86 Dermatitis or eczema of lower legs
|
EA87 Dermatitis or eczema of anogenital region
|
EA88 Miscellaneous specified eczematous dermatoses
|
EA89 Generalised eczematous dermatitis of unspecified type
|
EA8Y Other specified eczematous dermatosis
|
EA8Z Dermatitis or eczema, unspecified
|
Papulosquamous dermatoses
|
Urticaria, angioedema or other urticarial disorders
|
EB00 Spontaneous urticaria
|
EB01 Inducible urticaria or angioedema
|
EB02 Cholinergic urticaria or related conditions
|
EB02.0 Cholinergic urticaria
EB02.Y Other conditions mediated by cholinergic activation
|
EB03 Syndromes with urticarial reactions or angioedema
|
EB04 Idiopathic angioedema
|
EB05 Urticaria of unspecified type
|
EB0Y Other specified urticarial disorders
|
Inflammatory erythemas and other reactive inflammatory dermatoses
|
Immunobullous diseases of the skin
|
Cutaneous lupus erythematosus
|
Scarring or sclerosing inflammatory dermatoses
|
EB7Y Other specified inflammatory dermatoses
|
Metabolic or nutritional disorders affecting the skin
|
Genetic or developmental disorders affecting the skin
|
Sensory or psychological disorders affecting the skin
|
Skin disorders involving specific cutaneous structures
|
Disorders of the epidermis or epidermal appendages
|
Disorders of epidermal keratinisation
|
Disorders of skin colour
|
Disorders of hair
|
Disorders of the hair follicle
|
Acne or related disorders
|
ED80 Acne
|
ED80.0 Comedonal acne
|
ED80.1 Superficial mixed comedonal and papulopustular acne
|
ED80.2 Papulopustular acne
|
ED80.3 Nodular acne
|
ED80.4 Severe inflammatory acne
|
ED80.40 Acne fulminans
ED80.41 Acne conglobata
ED80.4Y Other specified severe inflammatory acne
ED80.4Z Severe inflammatory acne, unspecified
|
ED80.5 Acne scarring
|
ED80.6 Infantile acne
|
ED80.Y Other specified acne
|
ED80.Z Acne, unspecified
|
ED81 Acneiform inflammatory disorders
|
ED81.0 Folliculitis cruris pustulosa atrophicans
ED81.1 Acneiform reactions to halogenated aromatic hydrocarbons
ED81.Y Other specified acneiform inflammatory disorders
ED81.Z Acneiform inflammatory disorders, unspecified
|
ED90 Rosacea or related disorders
|
ED90.0 Rosacea
|
ED90.00 Erythematotelangiectatic rosacea
ED90.01 Papulopustular rosacea
ED90.02 Phymatous rosacea
ED90.0Y Other specified rosacea
ED90.0Z Rosacea, unspecified
|
ED90.1 Periorificial dermatitis
|
ED90.Y Other specified rosacea-like disorders
|
ED90.Z Rosacea-like disorders unspecified
|
ED91 Disorders of the sebaceous gland
|
ED92 Disorders involving the apocrine follicular unit
|
ED9Y Other specified disorders involving the hair follicle
|
Disorders of eccrine sweat glands or sweating
|
Disorders of the nail or perionychium
|
Disorders of epidermal integrity
|
Disorders of the dermis or subcutis
|
Disorders of cutaneous connective tissue
|
EE40 Atrophy or degeneration of dermal or subcutaneous connective tissue
|
EE40.0 Corticosteroid-induced skin atrophy
|
EE40.1 Stretch marks
|
EE40.2 Atrophic scarring of the skin
|
EE40.3 Skin fragility
|
EE40.30 Genetically-determined skin fragility
EE40.31 Age-related skin fragility
EE40.32 Purpura or bruising due to vascular fragility
|
EE40.Y Other specified atrophy or degeneration of dermal or subcutaneous connective tissue
|
EE40.Z Atrophy or degeneration of dermal or subcutaneous connective tissue, unspecified type
|
EE41 Abnormalities of dermal elastin
|
Poikiloderma
|
Fibromatoses or keloids
|
EE70 Perforating dermatoses
|
EE7Y Other specified disorders of cutaneous connective tissue
|
Histiocytic-granulomatous disorders of the skin
|
Benign dermal lymphocytic or lymphoplasmacytic infiltrations or proliferations
|
Disorders of subcutaneous fat
|
Disorders of cutaneous blood or lymphatic vessels
|
Skin disorders involving certain specific body regions
|
Skin disorders associated with pregnancy, the neonatal period or infancy
|
Adverse cutaneous reactions to medication
|
Skin disorders provoked by external factors
|
EH90 Pressure ulceration
|
EH92 Dermatoses provoked by friction or mechanical stress
|
EH93 Dermatoses due to foreign bodies in the skin
|
EH94 Scar of skin, not elsewhere classified
|
Dermatoses provoked or exacerbated by exposure to cold
|
Dermatoses provoked by heat or electricity
|
Dermatoses provoked by light or UV radiation
|
Dermatoses due to ionizing radiation
|
EK00 Allergic contact dermatitis
|
EK01 Photo-allergic contact dermatitis
|
EK02 Irritant contact dermatitis
|
EK02.0 Irritant contact dermatitis from specified external agents
|
EK02.2 Irritant contact dermatitis due to friction, sweating or contact with body fluids
|
EK02.20 Intertriginous dermatitis due to friction, sweating or contact with body fluids
EK02.21 Irritant contact dermatitis due to saliva
EK02.22 Irritant contact dermatitis due to incontinence
EK02.23 Irritant contact dermatitis related to stoma or fistula
EK02.24 Irritant contact dermatitis related to skin contact with prostheses or surgical appliances
|
EK02.Y Irritant contact dermatitis due to other specified cause
|
EK02.Z Irritant contact dermatitis, unspecified
|
EK10 Allergic contact urticaria
|
EK11 Protein contact dermatitis
|
EK12 Allergic contact sensitisation
|
Phototoxic reactions to skin contact with photoactive agents
|
EK50 Cutaneous reactions to venomous or noxious animals
|
EK5Y Other specified skin disorders provoked by external factors
|
Benign proliferations, neoplasms and cysts of the skin
|
Disorders of the skin of uncertain or unpredictable malignant potential
|
Cutaneous markers of internal disorders
|
Postprocedural disorders of the skin
|
EM0Y Other specified diseases of the skin
|
EM0Z Skin disease of unspecified nature
|
|
15 Diseases of the musculoskeletal system or connective tissue
|
Arthropathies
|
Osteoarthritis
|
Infection related arthropathies
|
FA10 Direct infections of joint
|
FA11 Reactive arthropathies
|
FA12 Postinfectious arthropathies
|
FA13 Infectious spondyloarthritis
|
FA1Y Other specified infection related arthropathies
|
FA1Z Infection related arthropathies, unspecified
|
Inflammatory arthropathies
|
FA20 Rheumatoid arthritis
|
FA21 Psoriatic arthritis
|
FA22 Polymyalgia rheumatica
|
FA23 Adult-onset Still disease
|
FA24 Juvenile idiopathic arthritis
|
FA24.0 Juvenile idiopathic oligoarthritis
|
FA24.1 Juvenile idiopathic polyarthritis
|
FA24.2 Juvenile psoriatic arthritis
|
FA24.3 Juvenile enthesitis related arthritis
|
FA24.4 Juvenile systemic arthritis
|
FA24.Y Other specified juvenile idiopathic arthritis
|
FA24.Z Juvenile idiopathic arthritis, unspecified
|
FA25 Gout
|
FA26 Certain specified crystal arthropathies
|
FA27 Certain specified inflammatory arthropathies
|
FA2Z Inflammatory arthropathies, unspecified
|
Certain specified joint disorders or deformities of limbs
|
FA5Z Arthropathies, unspecified
|
Conditions associated with the spine
|
Soft tissue disorders
|
Disorders of muscles
|
Disorders of synovium or tendon
|
Miscellaneous specified soft tissue disorders
|
FB50 Bursitis
|
FB50.0 Infectious bursitis
FB50.1 Bursitis related to use, overuse or pressure
FB50.2 Synovial cyst of popliteal space
FB50.3 Calcium deposit in bursa
FB50.Y Other specified bursitis
FB50.Z Bursitis, unspecified
|
FB51 Fibroblastic disorders
|
FB52 Soft tissue disorders in diseases classified elsewhere
|
FB53 Shoulder lesions
|
FB54 Enthesopathies of lower limb
|
FB55 Certain specified enthesopathies
|
FB56 Specified soft tissue disorders, not elsewhere classified
|
FB6Z Soft tissue disorders, unspecified
|
Osteopathies or chondropathies
|
FB80 Certain specified disorders of bone density or structure
|
FB81 Osteonecrosis
|
FB82 Chondropathies
|
FB82.0 Chondromalacia
|
FB82.1 Osteochondrosis or osteochondritis dissecans
|
FB82.2 Slipped upper femoral epiphysis
|
FB82.3 Relapsing polychondritis
|
FB82.Y Other specified chondropathies
|
FB82.Z Chondropathies, unspecified
|
FB83 Low bone mass disorders
|
FB84 Osteomyelitis or osteitis
|
FB85 Paget disease of bone
|
FB86 Disorders associated with bone growth
|
FB8Y Other specified osteopathies or chondropathies
|
FB8Z Osteopathies or chondropathies, unspecified
|
FC00 Certain specified acquired deformities of musculoskeletal system or connective tissue, not elsewhere classified
|
FC01 Postprocedural disorders of the musculoskeletal system
|
FC0Y Other specified diseases of the musculoskeletal system or connective tissue
|
FC0Z Diseases of the musculoskeletal system or connective tissue, unspecified
|
|
16 Diseases of the genitourinary system
|
Diseases of the female genital system
|
Inflammatory disorders of the female genital tract
|
GA10 Endometriosis
|
GA10.B Endometriosis of the reproductive system
|
GA10.C Endometriosis of the digestive system
|
GA10.D Endometriosis of urinary system
|
GA10.E Endometriosis of the circulatory system
|
GA10.F Endometriosis of the nervous system
|
GA10.G Thoracic endometriosis
|
GA10.H Endometriosis in cutaneous scar
|
GA10.J Endometriosis-related adhesions
|
GA10.Y Endometriosis of other specified sites
|
GA10.Z Endometriosis of unspecified site
|
GA11 Adenomyosis
|
Noninflammatory disorders of female genital tract
|
Abnormal uterine or vaginal bleeding
|
GA30 Menopausal or perimenopausal disorders
|
GA31 Female infertility
|
GA32 Complications associated with medically assisted reproduction
|
GA33 Recurrent pregnancy loss
|
GA34 Female pelvic pain associated with genital organs or menstrual cycle
|
GA34.0 Pain related to vulva, vagina or pelvic floor
|
GA34.00 Vulval pain
GA34.01 Perineal pain
GA34.02 Vulvodynia
GA34.0Y Other specified pain related to vulva, vagina or pelvic floor
GA34.0Z Pain related to vulva, vagina or pelvic floor, unspecified
|
GA34.1 Vaginal laxity
|
GA34.2 Female pelvic pain
|
GA34.3 Dysmenorrhoea
|
GA34.4 Premenstrual disturbances
|
GA34.5 Ovarian remnant syndrome
|
GA34.6 Female genital pain
|
GA34.Y Other specified female pelvic pain associated with genital organs or menstrual cycle
|
GA34.Z Female pelvic pain associated with genital organs or menstrual cycle, unspecified
|
Dermatoses of female genitalia
|
GA6Y Other specified diseases of the female genital system
|
GA6Z Diseases of the female genital system, unspecified
|
Diseases of the male genital system
|
Disorders of breast
|
Diseases of the urinary system
|
Glomerular diseases
|
Renal tubulo-interstitial diseases
|
Kidney failure
|
Urolithiasis
|
Cystic or dysplastic kidney disease
|
GB90 Certain specified disorders of kidney or ureter
|
Certain specified diseases of urinary system
|
GC00 Cystitis
|
GC01 Other disorders of bladder
|
GC02 Urethritis and urethral syndrome
|
GC03 Urethral stricture
|
GC04 Fistula of the genitourinary tract
|
GC04.0 Urethral fistula
|
GC04.1 Fistulae involving female genital tract
|
GC04.10 Vesicovaginal fistula
GC04.11 Fistula of small intestine to vagina
GC04.12 Fistula of large intestine to vagina
GC04.13 Female genital tract-skin fistulae
GC04.14 Urethrovaginal fistula
GC04.15 Combined urethrovesicovaginal fistula
GC04.16 Rectovaginal fistula
GC04.17 Vesicouterine fistula with severe scar or extensive tissue loss
GC04.18 Other combined urinary fistula with severe scar or extensive tissue loss
GC04.19 Combined urinary and rectal fistula including cloaca with severe scar or extensive tissue loss
GC04.1A Vaginal stenosis or gynatresia related to obstetric fistula
GC04.1Y Other specified fistulae involving female genital tract
GC04.1Z Fistulae involving female genital tract, unspecified
|
GC04.2 Ureteral fistula
|
GC04.Y Other specified fistula of the genitourinary tract
|
GC04.Z Fistula of the genitourinary tract, unspecified
|
GC05 Prolapsed urethral mucosa
|
GC06 Urethral diverticulum
|
GC07 Urethral caruncle
|
GC08 Urinary tract infection, site not specified
|
GC0Y Other diseases of urinary system
|
GC2Z Diseases of the urinary system, unspecified
|
Other conditions of the genitourinary system
|
Postprocedural disorders of genitourinary system
|
GC8Y Other specified diseases of the genitourinary system
|
GC8Z Diseases of the genitourinary system, unspecified
|
|
17 Conditions related to sexual health
|
Sexual dysfunctions
|
Sexual pain disorders
|
HA40 Aetiological considerations in sexual dysfunctions and sexual pain disorders
|
HA40.0 Aetiological considerations associated with a medical condition, injury, or the effects of surgery or radiation treatment
HA40.1 Aetiological considerations associated with psychological or behavioural factors, including mental disorders
HA40.2 Aetiological considerations associated with use of psychoactive substance or medication
HA40.3 Aetiological considerations associated with lack of knowledge or experience
HA40.4 Aetiological considerations associated with relationship factors
HA40.5 Aetiological considerations associated with cultural factors
HA40.Y Other specified aetiological considerations in sexual dysfunctions and sexual pain disorders
|
Gender incongruence
|
HA8Y Other specified conditions related to sexual health
|
HA8Z Conditions related to sexual health, unspecified
|
|
18 Pregnancy, childbirth or the puerperium
|
Abortive outcome of pregnancy
|
Oedema, proteinuria, or hypertensive disorders in pregnancy, childbirth, or the puerperium
|
Obstetric haemorrhage
|
Certain specified maternal disorders predominantly related to pregnancy
|
JA60 Excessive vomiting in pregnancy
|
JA61 Venous complications in pregnancy
|
JA62 Infections of genitourinary tract in pregnancy
|
JA63 Diabetes mellitus in pregnancy
|
JA64 Malnutrition in pregnancy
|
JA65 Maternal care for other conditions predominantly related to pregnancy
|
JA65.0 Liver disorders in pregnancy, childbirth or the puerperium
|
JA65.1 Pregnancy dermatoses
|
JA65.2 Excessive weight gain in pregnancy
|
JA65.3 Low weight gain in pregnancy
|
JA65.4 Pregnancy care of habitual aborter
|
JA65.5 Retained intrauterine contraceptive device in pregnancy
|
JA65.6 Maternal hypotension syndrome
|
JA65.7 Subluxation of symphysis pubis in pregnancy, childbirth or the puerperium
|
JA65.Y Maternal care for other specified conditions predominantly related to pregnancy
|
JA65.Z Maternal care for unspecified conditions predominantly related to pregnancy
|
JA66 Clinical findings on antenatal screening of mother
|
JA67 Complications of anaesthesia during pregnancy
|
JA6Z Maternal disorders predominantly related to pregnancy, unspecified
|
Maternal care related to the fetus, amniotic cavity or possible delivery problems
|
JA80 Maternal care related to multiple gestation
|
JA80.0 Twin pregnancy
JA80.1 Triplet pregnancy
JA80.2 Quadruplet pregnancy
JA80.Y Maternal care related to other specified multiple gestation
JA80.Z Maternal care related to unspecified multiple gestation
|
JA81 Maternal care related to complications specific to multiple gestation
|
JA81.0 Papyraceous fetus
JA81.1 Continuing pregnancy after abortion of one fetus or more
JA81.2 Continuing pregnancy after intrauterine death of one fetus or more
JA81.3 Loss of pregnancy after abortion or intrauterine death of one fetus or more
JA81.Y Other specified maternal care related to complications specific to multiple gestation
JA81.Z Maternal care related to complications specific to multiple gestation, unspecified
|
JA82 Maternal care for malpresentation of fetus
|
JA83 Maternal care for disproportion
|
JA84 Maternal care for abnormality of pelvic organs
|
JA85 Maternal care for fetal abnormality or damage
|
JA86 Maternal care for other fetal problems
|
JA87 Maternal care related to polyhydramnios
|
JA88 Maternal care related to certain specified disorders of amniotic fluid or membranes
|
JA88.0 Oligohydramnios
JA88.1 Infection of amniotic sac or membranes
JA88.Y Other specified disorders of amniotic fluid and membranes
JA88.Z Disorders of amniotic fluid and membranes, unspecified
|
JA89 Maternal care related to premature rupture of membranes
|
JA89.0 Premature rupture of membranes, onset of labour within 24 hours
JA89.1 Premature rupture of membranes, onset of labour after 24 hours
JA89.2 Premature rupture of membranes, labour delayed by therapy
JA89.3 Preterm premature rupture of membranes
JA89.Y Other specified maternal care related to premature rupture of membranes
JA89.Z Maternal care related to premature rupture of membranes, unspecified
|
JA8A Maternal care related to placental disorders
|
JA8A.0 Placental transfusion syndromes
JA8A.1 Malformation of placenta
JA8A.2 Morbidly adherent placenta
JA8A.Y Other specified maternal care related to placental disorders
JA8A.Z Maternal care related to placental disorders, unspecified
|
JA8B Maternal care related to placenta praevia or low lying placenta
|
JA8B.0 Placenta praevia specified as without haemorrhage
JA8B.1 Placenta praevia with haemorrhage
JA8B.Z Maternal care related to placenta praevia or low lying placenta, unspecified
|
JA8C Maternal care related to premature separation of placenta
|
JA8C.0 Premature separation of placenta with coagulation defect
JA8C.Y Other specified maternal care related to premature separation of placenta
JA8C.Z Maternal care related to premature separation of placenta, unspecified
|
JA8D Maternal care related to false labour
|
JA8D.0 False labour before 37 completed weeks of gestation
JA8D.1 False labour at or after 37 completed weeks of gestation
JA8D.Z Maternal care related to false labour, unspecified
|
JA8E Maternal care related to prolonged pregnancy
|
JA8Y Maternal care related to other specified fetus, amniotic cavity or possible delivery problems
|
JA8Z Maternal care related to unspecified fetus, amniotic cavity or possible delivery problems
|
Complications of labour or delivery
|
Delivery
|
Complications predominantly related to the puerperium
|
JB40 Infections in the puerperium
|
JB41 Venous complications in the puerperium
|
JB42 Obstetric embolism
|
JB43 Complications of anaesthesia during the puerperium
|
JB44 Certain specified complications of the puerperium
|
JB45 Infections of breast associated with childbirth
|
JB46 Certain specified disorders of breast or lactation associated with childbirth
|
JB4Z Complications predominantly related to the puerperium, unspecified
|
Certain obstetric conditions, not elsewhere classified
|
|
19 Certain conditions originating in the perinatal period
|
Fetus or newborn affected by maternal factors or by complications of pregnancy, labour or delivery
|
KA00 Fetus or newborn affected by maternal conditions that may be unrelated to present pregnancy
|
KA00.0 Fetus or newborn affected by maternal hypertensive disorders
|
KA00.1 Fetus or newborn affected by gestational oedema or proteinuria without hypertension
|
KA00.2 Fetus or newborn affected by maternal renal or urinary tract diseases
|
KA00.3 Fetus or newborn affected by maternal infectious diseases
|
KA00.4 Fetus or newborn affected by periodontal disease in mother
|
KA00.5 Fetus or newborn affected by maternal respiratory diseases
|
KA00.6 Fetus or newborn affected by maternal nutritional disorders
|
KA00.7 Fetus or newborn affected by abnormal maternal chemistry
|
KA00.8 Fetus or newborn affected by maternal injury
|
KA00.9 Fetus or newborn affected by maternal chemotherapy
|
KA00.A Fetus or newborn affected by surgical procedure on mother
|
KA00.B Fetus or newborn affected by maternal anaemia
|
KA00.Y Fetus or newborn affected by other specified maternal condition that may be unrelated to present pregnancy
|
KA00.Z Fetus or newborn affected by unspecified maternal condition that may be unrelated to present pregnancy
|
KA01 Fetus or newborn affected by maternal complications of pregnancy
|
KA02 Fetus or newborn affected by complications of placenta
|
KA03 Fetus or newborn affected by complications of umbilical cord
|
KA04 Fetus or newborn affected by other abnormalities of membranes
|
KA05 Fetus or newborn affected by certain complications of labour or delivery
|
KA06 Fetus or newborn affected by noxious influences transmitted via placenta or breast milk
|
KA07 Neonatal dermatoses due to maternal antibodies
|
KA0Z Fetus or newborn affected by unspecified maternal factors or by complications of pregnancy, labour or delivery
|
Disorders of newborn related to length of gestation or fetal growth
|
KA20 Disorders of newborn related to slow fetal growth or fetal malnutrition
|
KA20.0 Small for gestational age
|
KA20.1 Intrauterine growth restriction
|
KA20.2 Fetal intrauterine malnutrition without mention of small for gestational age
|
KA20.Y Other specified disorders of newborn related to slow fetal growth or fetal malnutrition
|
KA20.Z Disorders of newborn related to slow fetal growth or fetal malnutrition, unspecified
|
KA21 Disorders of newborn related to short gestation or low birth weight, not elsewhere classified
|
KA21.0 Extremely low birth weight of newborn
|
KA21.00 Extremely low birth weight of newborn, 499g or less
KA21.01 Extremely low birth weight of newborn, 500-749g
KA21.02 Extremely low birth weight of newborn, 750-999g
KA21.0Z Extremely low birth weight of newborn, unspecified
|
KA21.1 Very low birth weight of newborn
|
KA21.10 Very low birth weight of newborn, 1000-1249g
KA21.11 Very low birth weight of newborn, 1250-1499g
KA21.1Z Very low birth weight of newborn, unspecified
|
KA21.2 Low birth weight of newborn
|
KA21.20 Low birth weight of newborn, 1500-1999g
KA21.21 Low birth weight of newborn, 2000-2499g
KA21.2Z Low birth weight of newborn, unspecified
|
KA21.3 Extreme prematurity of newborn
|
KA21.30 Extreme prematurity of newborn, gestational age less than 22 completed weeks
KA21.31 Extreme prematurity of newborn, gestational age 22 completed weeks
KA21.32 Extreme prematurity of newborn, gestational age 23 completed weeks
KA21.33 Extreme prematurity of newborn, gestational age 24 completed weeks
KA21.34 Extreme prematurity of newborn, gestational age 25 completed weeks
KA21.35 Extreme prematurity of newborn, gestational age 26 completed weeks
KA21.36 Extreme prematurity of newborn, gestational age 27 completed weeks
KA21.3Z Extreme prematurity of newborn, unspecified
|
KA21.4 Preterm newborn
|
KA21.40 Preterm newborn, gestational age 28 completed weeks
KA21.41 Preterm newborn, gestational age 29 completed weeks
KA21.42 Preterm newborn, gestational age 30 completed weeks
KA21.43 Preterm newborn, gestational age 31 completed weeks
KA21.44 Preterm newborn, gestational age 32 completed weeks
KA21.45 Preterm newborn, gestational age 33 completed weeks
KA21.46 Preterm newborn, gestational age 34 completed weeks
KA21.47 Preterm newborn, gestational age 35 completed weeks
KA21.48 Preterm newborn, gestational age 36 completed weeks
KA21.4Z Preterm newborn, unspecified
|
KA22 Disorders of newborn related to long gestation or high birth weight
|
KA22.0 Exceptionally large newborn
KA22.1 Large newborn for gestational age
KA22.2 Post-term newborn
KA22.3 Postmaturity syndrome
|
KA2Y Other specified disorders of newborn related to length of gestation or fetal growth
|
KA2Z Disorders of newborn related to length of gestation or fetal growth, unspecified
|
Birth injury
|
Infections of the fetus or newborn
|
Haemorrhagic or haematological disorders of fetus or newborn
|
Neurological disorders specific to the perinatal or neonatal period
|
Respiratory disorders specific to the perinatal or neonatal period
|
KB20 Intrauterine hypoxia
|
KB21 Birth asphyxia
|
KB22 Metabolic acidaemia in newborn
|
KB23 Respiratory distress of newborn
|
KB24 Congenital pneumonia
|
KB25 Neonatal tracheitis
|
KB26 Neonatal aspiration syndromes
|
KB27 Pulmonary air leak or related conditions originating in the perinatal period
|
KB27.0 Interstitial emphysema originating in the perinatal period
KB27.1 Pneumothorax originating in the perinatal period
KB27.2 Pneumomediastinum originating in the perinatal period
KB27.3 Pneumopericardium originating in the perinatal period
KB27.4 Pneumoperitoneum, originating in the perinatal period, due to primary pulmonary air leak syndromes
KB27.Y Other specified pulmonary air leak or related conditions originating in the perinatal period
KB27.Z Pulmonary air leak or related conditions originating in the perinatal period, unspecified
|
KB28 Pulmonary haemorrhage originating in the perinatal period
|
KB29 Chronic respiratory disease originating in the perinatal period
|
KB2A Apnoea of newborn
|
KB2B Primary atelectasis of newborn
|
KB2C Cyanotic attacks of newborn
|
KB2D Respiratory failure of newborn
|
KB2E Respiratory arrest of newborn
|
KB2F Congenital lung or lobar atelectasis
|
KB2G Tracheal haemorrhage of newborn due to airway trauma
|
KB2H Acquired vocal cord paralysis in newborn
|
KB2J Airway obstruction in the neonate due to airway abnormality
|
KB2K Pulmonary cysts in newborn
|
KB2Y Other specified respiratory disorders specific to the perinatal or neonatal period
|
KB2Z Respiratory disorders specific to the perinatal or neonatal period, unspecified
|
Cardiovascular disorders present in the perinatal or neonatal period
|
Transitory endocrine or metabolic disorders specific to fetus or newborn
|
Digestive system disorders of fetus or newborn
|
Genitourinary system disorders specific to the perinatal or neonatal period
|
Disorders involving the integument of fetus or newborn
|
Disturbances of temperature regulation of newborn
|
Certain disorders originating in the perinatal period
|
KD5Z Conditions originating in the perinatal or neonatal period, unspecified
|
|
20 Developmental anomalies
|
Structural developmental anomalies primarily affecting one body system
|
Structural developmental anomalies of the nervous system
|
Structural developmental anomalies of the eye, eyelid or lacrimal apparatus
|
Structural developmental anomalies of the ear
|
Structural developmental anomalies of the face, mouth or teeth
|
Structural developmental anomalies of the neck
|
Structural developmental anomalies of the respiratory system
|
Structural developmental anomalies of the circulatory system
|
Structural developmental anomaly of heart or great vessels
|
LA80 Anomalous position-orientation of heart
|
LA81 Abnormal ventricular relationships
|
LA82 Total mirror imagery
|
LA83 Right isomerism
|
LA84 Left isomerism
|
LA85 Congenital anomaly of an atrioventricular or ventriculo-arterial connection
|
LA86 Congenital anomaly of mediastinal vein
|
LA87 Congenital anomaly of an atrioventricular valve or atrioventricular septum
|
LA88 Congenital anomaly of a ventricle or the ventricular septum
|
LA89 Functionally univentricular heart
|
LA8A Congenital anomaly of a ventriculo-arterial valve or adjacent regions
|
LA8B Congenital anomaly of great arteries including arterial duct
|
LA8C Congenital anomaly of coronary artery
|
LA8D Congenital pericardial anomaly
|
LA8E Congenital anomaly of atrial septum
|
LA8F Congenital anomaly of right atrium
|
LA8G Congenital anomaly of left atrium
|
LA8Y Other specified structural developmental anomaly of heart or great vessels
|
LA8Z Structural developmental anomaly of heart or great vessels, unspecified
|
LA90 Structural developmental anomalies of the peripheral vascular system
|
LA9Y Other specified structural developmental anomalies of the circulatory system
|
LA9Z Structural developmental anomalies of the circulatory system, unspecified
|
Structural developmental anomalies of the diaphragm, abdominal wall or umbilical cord
|
Structural developmental anomalies of the digestive tract
|
Structural developmental anomalies of the liver, biliary tract, pancreas or spleen
|
Structural developmental anomalies of the urinary system
|
Structural developmental anomalies of the female genital system
|
Structural developmental anomalies of the male genital system
|
Structural developmental anomalies of the breast
|
Structural developmental anomalies of the skeleton
|
Structural developmental anomalies of the skin
|
Structural developmental anomalies of the adrenal glands
|
LD0Y Other specified structural developmental anomalies primarily affecting one body system
|
LD0Z Structural developmental anomalies primarily affecting one body system, unspecified
|
Multiple developmental anomalies or syndromes
|
LD20 Syndromes with central nervous system anomalies as a major feature
|
LD21 Syndromes with eye anomalies as a major feature
|
LD22 Syndromes with dental anomalies as a major feature
|
LD23 Syndromes with vascular anomalies as a major feature
|
LD24 Syndromes with skeletal anomalies as a major feature
|
LD25 Syndromes with face or limb anomalies as a major feature
|
LD26 Syndromes with limb anomalies as a major feature
|
LD27 Syndromes with skin or mucosal anomalies as a major feature
|
LD28 Syndromes with connective tissue involvement as a major feature
|
LD28.0 Marfan syndrome or Marfan-related disorders
|
LD28.00 Congenital contractural arachnodactyly
LD28.01 Marfan syndrome
LD28.0Y Other specified Marfan syndrome or Marfan-related disorders
LD28.0Z Marfan syndrome or Marfan-related disorders, unspecified
|
LD28.1 Ehlers-Danlos syndrome
|
LD28.2 Genetically-determined cutis laxa
|
LD28.Y Other specified syndromes with connective tissue involvement as a major feature
|
LD28.Z Syndromes with connective tissue involvement as a major feature, unspecified
|
LD29 Syndromes with obesity as a major feature
|
LD2A Malformative disorders of sex development
|
LD2B Syndromes with premature ageing appearance as a major feature
|
LD2C Overgrowth syndromes
|
LD2D Phakomatoses or hamartoneoplastic syndromes
|
LD2E Syndromes with structural anomalies due to inborn errors of metabolism
|
LD2F Syndromes with multiple structural anomalies, without predominant body system involvement
|
LD2F.0 Toxic or drug-related embryofetopathies
|
LD2F.00 Fetal alcohol syndrome
LD2F.01 Fetal hydantoin syndrome
LD2F.02 Embryofetopathy due to oral anticoagulant therapy
LD2F.03 Fetal Valproate Spectrum Disorder
LD2F.0Y Other specified toxic or drug-related embryofetopathies
LD2F.0Z Toxic or drug-related embryofetopathies, unspecified
|
LD2F.1 Syndromes with multiple structural anomalies, not of environmental origin
|
LD2F.Y Other specified syndromes with multiple structural anomalies, without predominant body system involvement
|
LD2F.Z Syndromes with multiple structural anomalies, without predominant body system involvement, unspecified
|
LD2G Conjoined twins
|
LD2H Syndromic genetic deafness
|
LD2Y Other specified multiple developmental anomalies or syndromes
|
LD2Z Multiple developmental anomalies or syndromes, unspecified
|
Chromosomal anomalies, excluding gene mutations
|
LD90 Conditions with disorders of intellectual development as a relevant clinical feature
|
LD9Y Other specified developmental anomalies
|
LD9Z Developmental anomalies, unspecified
|
|
21 Symptoms, signs or clinical findings, not elsewhere classified
|
Symptoms, signs or clinical findings of blood, blood-forming organs, or the immune system
|
Symptoms, signs or clinical findings of endocrine, nutritional or metabolic diseases
|
Symptoms, signs or clinical findings of speech, language or voice
|
Mental or behavioural symptoms, signs or clinical findings
|
MB20 Symptoms, signs or clinical findings involving consciousness
|
MB21 Symptoms, signs or clinical findings involving cognition
|
MB22 Symptoms or signs involving motivation or energy
|
MB23 Symptoms or signs involving appearance or behaviour
|
MB24 Symptoms or signs involving mood or affect
|
MB25 Symptoms or signs involving form of thought
|
MB26 Symptoms or signs involving content of thought
|
MB27 Symptoms or signs involving perceptual disturbance
|
MB28 Symptoms or signs related to personality features
|
MB28.0 Attention seeking
MB28.1 Callousness
MB28.2 Eccentricity
MB28.3 Entitlement
MB28.4 Hostility
MB28.5 Impulsivity
MB28.6 Indecisiveness
MB28.7 Irresponsibility
MB28.8 Low frustration tolerance
MB28.9 Low self-esteem
MB28.A Negative affectivity
MB28.B Negativism
MB28.C Perfectionism
MB28.D Pessimism
MB28.E Recklessness
MB28.F Sensation seeking
MB28.G Stubbornness
MB28.H Submissiveness
MB28.Y Other specified symptoms and signs related to personality features
MB28.Z Symptoms and signs related to personality features, unspecified
|
MB29 Symptoms or signs involving eating and related behaviour
|
MB29.0 Avoidant or restrictive eating
MB29.1 Binge eating
MB29.2 Eating of non-nutritive substances
MB29.3 Purging behaviour
MB29.4 Rumination-regurgitation
MB29.Y Other specified symptoms and signs involving eating and related behaviour
MB29.Z Symptoms and signs involving eating and related behaviour, unspecified
|
MB2A Symptoms or signs involving elimination
|
MB2Y Other specified mental or behavioural symptoms, signs or clinical findings
|
Symptoms, signs or clinical findings of the nervous system
|
Symptoms, signs or clinical findings of the visual system
|
Symptoms, signs or clinical findings of ear or mastoid process
|
Symptoms, signs or clinical findings of the circulatory system
|
Symptoms, signs or clinical findings of the respiratory system
|
Symptoms or signs involving the respiratory system
|
MD10 Abnormal sputum
|
MD11 Abnormalities of breathing
|
MD11.0 Apnoea
|
MD11.1 Asphyxia
|
MD11.2 Ataxic breathing
|
MD11.3 Breath holding
|
MD11.4 Sleep related Cheyne-Stokes respiration
|
MD11.5 Dyspnoea
|
MD11.6 Hiccough
|
MD11.7 Hyperventilation
|
MD11.8 Mouth breathing
|
MD11.9 Nasal congestion
|
MD11.A Sneezing
|
MD11.B Stridor
|
MD11.C Wheezing
|
MD11.D Yawning
|
MD11.Y Other specified abnormalities of breathing
|
MD11.Z Abnormalities of breathing, unspecified
|
MD12 Cough
|
Haemorrhage from respiratory passages
|
MD30 Pain in throat or chest
|
MD31 Pleurisy
|
MD32 Rales
|
MD33 Respiratory arrest
|
MD34 Symptom or complaint of the nose
|
MD35 Symptom or complaint of the sinus
|
MD36 Symptom or complaint of the throat
|
MD3Y Other specified symptoms or signs involving the respiratory system
|
Clinical findings in the respiratory system
|
MD6Y Other specified symptoms, signs or clinical findings of the respiratory system
|
Symptoms, signs or clinical findings of the digestive system or abdomen
|
Symptoms or signs involving the digestive system or abdomen
|
MD80 Symptoms or signs of the orofacial complex
|
MD81 Abdominal or pelvic pain
|
MD82 Intra-abdominal or pelvic swelling, mass or lump
|
Symptoms related to the upper gastrointestinal tract
|
MD90 Nausea or vomiting
|
MD91 Belching
|
MD92 Dyspepsia
|
MD93 Dysphagia
|
MD94 Halitosis
|
MD95 Heartburn
|
MD9Y Other specified symptoms related to the upper gastrointestinal tract
|
Symptoms related to the lower gastrointestinal tract or abdomen
|
ME00 Abdominal compartment syndrome
|
ME01 Abdominal distension
|
ME02 Abdominal rigidity
|
ME03 Abnormal bowel sounds
|
ME04 Ascites
|
ME05 Change in bowel habit
|
ME06 Chronic enteritis of uncertain aetiology
|
ME07 Faecal incontinence
|
ME08 Flatulence or related conditions
|
ME09 Rectal tenesmus
|
ME0A Visible peristalsis
|
ME0B Problems with defaecation, not otherwise specified
|
ME0Y Other specified symptoms related to the lower gastrointestinal tract or abdomen
|
ME10 Abnormalities related to hepatobiliary system
|
ME10.0 Hepatomegaly or splenomegaly
|
ME10.00 Hepatomegaly, not elsewhere classified
ME10.01 Splenomegaly, not elsewhere classified
ME10.02 Hepatomegaly with splenomegaly
|
ME10.1 Unspecified jaundice
|
ME1Y Other specified symptoms or signs involving the digestive system or abdomen
|
Clinical findings in the digestive system or abdomen
|
ME4Y Other specified symptoms, signs or clinical findings of the digestive system or abdomen
|
Symptoms, signs or clinical findings involving the skin
|
Symptoms or signs involving the skin
|
ME60 Skin lesion of uncertain or unspecified nature
|
ME61 Subcutaneous swelling, mass or lump of uncertain or unspecified nature
|
ME62 Acute skin eruption of uncertain or unspecified nature
|
ME63 Chronic skin disorder of uncertain or unspecified nature
|
ME64 Non-specific cutaneous vascular signs
|
ME65 Disturbances of skin sensation of unspecified aetiology
|
ME66 Miscellaneous non-specific skin-related symptoms or signs
|
ME66.0 Abnormal sensitivity to light or UV radiation of uncertain or unspecified nature
|
ME66.1 Changes in skin texture
|
ME66.2 Excess and redundant skin
|
ME66.3 Symptom or complaint relating to hair or scalp
|
ME66.4 Symptom or complaint relating to nails
|
ME66.5 Complaint of abnormal sweating
|
ME66.6 Rash
|
ME66.Y Other specified skin changes
|
ME67 Skin disorder of uncertain or unspecified nature
|
ME6Y Other specified symptoms or signs involving the skin
|
Symptoms, signs or clinical findings of the musculoskeletal system
|
Symptoms, signs or clinical findings of the genitourinary system
|
General symptoms, signs or clinical findings
|
General symptoms
|
MG20 Cachexia
|
MG21 Chills
|
MG22 Fatigue
|
MG23 Fear of death or dying
|
MG24 Fear of disease
|
MG25 Feeling ill
|
MG26 Fever of other or unknown origin
|
MG27 Haemorrhage, not elsewhere classified
|
MG28 Hypothermia, not associated with low environmental temperature
|
MG29 Oedema
|
MG2A Ageing associated decline in intrinsic capacity
|
Pain
|
MG30 Chronic pain
|
MG30.0 Chronic primary pain
|
MG30.1 Chronic cancer related pain
|
MG30.10 Chronic cancer pain
MG30.11 Chronic post cancer treatment pain
MG30.1Y Other specified chronic cancer related pain
MG30.1Z Chronic cancer related pain, unspecified
|
MG30.2 Chronic postsurgical or post traumatic pain
|
MG30.3 Chronic secondary musculoskeletal pain
|
MG30.4 Chronic secondary visceral pain
|
MG30.5 Chronic neuropathic pain
|
MG30.6 Chronic secondary headache or orofacial pain
|
MG30.Y Other specified chronic pain
|
MG30.Z Chronic pain, unspecified
|
MG31 Acute pain
|
MG3Z Pain, unspecified
|
MG40 Shock
|
MG41 Sleep disturbance, not elsewhere classified
|
MG42 Somnolence, not elsewhere classified
|
MG43 Symptoms or signs concerning food or fluid intake
|
MG44 Symptoms peculiar to infancy
|
MG45 Syncope or collapse
|
MG46 Systemic inflammatory response syndrome of noninfectious origin
|
MG47 Toxicosis not further specified
|
MG48 Unknown or unspecified causes of morbidity
|
MG49 Hangover
|
MG4A Multi organ failure
|
MG4Y Other specified general symptoms
|
Finding of microorganism resistant to antimicrobial drugs
|
Clinical findings in specimens from other specified organs, systems or tissues
|
Abnormal results, not elsewhere classified
|
Ill-defined or unknown causes of mortality
|
MH2Y Other specified symptoms, signs or clinical findings, not elsewhere classified
|
|
22 Injury, poisoning or certain other consequences of external causes
|
|
23 External causes of morbidity or mortality
|
Unintentional causes
|
Unintentional transport injury event
|
Unintentional fall
|
Unintentional contact with person, animal or plant
|
Unintentional exposure to object, not elsewhere classified
|
Unintentional immersion, submersion or falling into water
|
Unintentional threat to breathing
|
Unintentional exposure to thermal mechanism
|
Unintentional exposure to or harmful effects of substances
|
Unintentional exposure to or harmful effects of drugs, medicaments or biological substances
|
PB20 Unintentional exposure to or harmful effects of opioids or related analgesics
PB21 Unintentional exposure to or harmful effects of sedative hypnotic drugs or other CNS depressants
PB22 Unintentional exposure to or harmful effects of psychostimulants
PB23 Unintentional exposure to or harmful effects of cannabinoids or hallucinogens
PB24 Unintentional exposure to or harmful effects of analgesics, antipyretics or nonsteroidal anti-inflammatory drugs
PB25 Unintentional exposure to or harmful effects of antidepressants
PB26 Unintentional exposure to or harmful effects of antipsychotics
PB27 Unintentional exposure to or harmful effects of antiepileptics or antiparkinsonism drugs
PB28 Unintentional exposure to or harmful effects of other or unspecified drug, medicament or biological substance
PB29 Unintentional exposure to or harmful effects of multiple drugs, medicaments or biological substances
|
Unintentional exposure to or harmful effects of substances chiefly nonmedicinal as to source
|
Unintentional exposure to other mechanism
|
PB6Y Other unintentional cause of morbidity or mortality
|
PB6Z Unspecified unintentional cause of morbidity or mortality
|
Intentional self-harm
|
Intentional self-harm by transport injury event
|
Intentional self-harm by fall or jump
|
Intentional self-harm by contact with person, animal or plant
|
Intentional self-harm by exposure to object, not elsewhere classified
|
Intentional self-harm by immersion, submersion or falling into water
|
Intentional self-harm by threat to breathing
|
Intentional self-harm by exposure to thermal mechanism
|
Intentional self-harm by exposure to or harmful effects of substances
|
Intentional self-harm by exposure to or harmful effects of drugs, medicaments or biological substances
|
PC90 Intentional self-harm by exposure to or harmful effects of opioids or related analgesics
PC91 Intentional self-harm by exposure to or harmful effects of sedative hypnotic drugs or other CNS depressants
PC92 Intentional self-harm by exposure to or harmful effects of psychostimulants
PC93 Intentional self-harm by exposure to or harmful effects of cannabinoids or hallucinogens
PC94 Intentional self-harm by exposure to or harmful effects of analgesics, antipyretics or nonsteroidal anti-inflammatory drugs
PC95 Intentional self-harm by exposure to or harmful effects of antidepressants
PC96 Intentional self-harm by exposure to or harmful effects of antipsychotics
PC97 Intentional self-harm by exposure to or harmful effects of antiepileptics or antiparkinsonism drugs
PC98 Intentional self-harm by exposure to other or unspecified drug, medicament or biological substance
PC99 Intentional self-harm by exposure to or harmful effects of multiple drugs, medicaments or biological substances
|
Intentional self-harm by exposure to or harmful effects of substances chiefly nonmedicinal as to source
|
Intentional self-harm by exposure to other mechanism
|
PD3Y Other specified intentional self-harm
|
PD3Z Intentional self-harm, unspecified
|
Assault
|
Assault by transport events
|
Assault by causing a fall or jump
|
Assault by contact with person, animal or plant
|
Assault by exposure to object not elsewhere classified
|
Assault by immersion, submersion or falling into water
|
Assault by threat to breathing
|
Assault by exposure to thermal mechanism
|
Assault by exposure to or harmful effects of substances
|
Assault by exposure to or harmful effects of drugs, medicaments or biological substances
|
PE80 Assault by exposure to or harmful effects of opioids or related analgesics
PE81 Assault by exposure to or harmful effects of sedative, hypnotic drugs or other CNS depressants
PE82 Assault by exposure to or harmful effects of psychostimulants
PE83 Assault by exposure to or harmful effects of cannabinoids or hallucinogens
PE84 Assault by exposure to or harmful effects of analgesics, antipyretics or nonsteroidal anti-inflammatory drugs
PE85 Assault by exposure to or harmful effects of antidepressants
PE86 Assault by exposure to or harmful effects of antipsychotics
PE87 Assault by exposure to or harmful effects of antiepileptics or antiparkinsonism drugs
PE88 Assault by exposure to or harmful effects of other or unspecified drug, medicament or biological substance
PE89 Assault by exposure to or harmful effects of multiple drugs, medicaments or biological substances
PE8Y Other specified assault by exposure to or harmful effects of drugs, medicaments or biological substances
PE8Z Assault by exposure to or harmful effects of drugs, medicaments or biological substances, unspecified
|
Assault by exposure to or harmful effects of substances chiefly nonmedicinal as to source
|
Assault by exposure to other mechanism
|
PF2Y Other specified assault
|
PF2Z Assault, unspecified
|
Undetermined intent
|
Transport injury event of undetermined intent
|
Fall or jump with undetermined intent
|
Contact with person, animal or plant with undetermined intent
|
Contact with object, not elsewhere classified with undetermined intent
|
Immersion, submersion or falling into water with undetermined intent
|
Threat to breathing with undetermined intent
|
Exposure to thermal mechanism with undetermined intent
|
Exposure to or harmful effects of substances, undetermined intent
|
Exposure to or harmful effects of undetermined intent of drugs, medicaments or biological substances
|
PH40 Exposure to or harmful effects of undetermined intent of opioids or related analgesics
|
PH41 Exposure to or harmful effects of undetermined intent of sedative hypnotic drugs or other CNS depressants
|
PH42 Exposure to or harmful effects of undetermined intent of psychostimulants
|
PH43 Exposure to or harmful effects of undetermined intent of cannabinoids or hallucinogens
|
PH44 Exposure to or harmful effects of undetermined intent of analgesics, antipyretics or nonsteroidal anti-inflammatory drugs
|
PH45 Exposure to or harmful effects of undetermined intent of antidepressants
|
PH46 Exposure to or harmful effects of undetermined intent of antipsychotics
|
PH47 Exposure to or harmful effects of undetermined intent of antiepileptics or antiparkinsonism drugs
|
PH48 Exposure to or harmful effects of undetermined intent of other or unspecified drugs, medicaments or biological substances
|
PH49 Exposure to or harmful effects of undetermined intent of multiple drugs, medicaments or biological substances
|
Exposure to or harmful effects of undetermined intent of substances chiefly nonmedicinal as to source
|
Exposure to other mechanism with undetermined intent
|
PH8Y Other specified injury event of undetermined intent
|
PH8Z Unspecified injury event of undetermined intent
|
Exposure to extreme forces of nature
|
Maltreatment
|
Legal intervention
|
Armed conflict
|
Causes of healthcare related harm or injury
|
Surgical or other medical procedures associated with injury or harm in diagnostic or therapeutic use
|
PK80 Medical or surgical procedure associated with injury or harm in therapeutic use
|
PK81 Certain medical procedures associated with injury or harm in therapeutic use
|
PK81.0 Ventilation associated with injury or harm in therapeutic use
|
PK81.1 Extracorporeal life support procedure associated with injury or harm in therapeutic use
|
PK81.2 Aspiration or drainage of body cavity or fluid collection associated with injury or harm in therapeutic use
|
PK81.3 Acupuncture or related therapies associated with injury or harm in therapeutic use
|
PK81.30 Acupuncture cupping associated with injury or harm in therapeutic use
PK81.3Y Other specified acupuncture or related therapies associated with injury or harm in therapeutic use
PK81.3Z Acupuncture or related therapies associated with injury or harm in therapeutic use, unspecified
|
PK81.4 Bone marrow aspiration or biopsy associated with injury or harm in therapeutic use
|
PK81.5 Biopsy procedure, not elsewhere classified, associated with injury or harm in therapeutic use
|
PK81.6 Dialysis associated with injury or harm in therapeutic use
|
PK81.7 Injection or infusion for therapeutic or diagnostic purposes associated with injury or harm in therapeutic use
|
PK81.8 Insertion of tube associated with injury or harm in therapeutic use
|
PK81.9 Joint aspiration associated with injury or harm in therapeutic use
|
PK81.A Lumbar puncture associated with injury or harm in therapeutic use
|
PK81.B Manipulative therapies associated with injury or harm in therapeutic use
|
PK81.C Radiation therapy associated with injury or harm in therapeutic use
|
PK81.D Other specified medical procedure associated with injury or harm in therapeutic use
|
PK81.E Cardiopulmonary resuscitation associated with injury or harm in therapeutic use
|
PK81.F Needle stick associated with injury or harm in therapeutic use
|
PK8Y Other specified surgical or other medical procedures associated with injury or harm in diagnostic or therapeutic use
|
PK8Z Surgical or other medical procedures associated with injury or harm in diagnostic or therapeutic use, unspecified
|
Surgical or other medical devices, implants or grafts associated with injury or harm in therapeutic use
|
Substances associated with injury or harm in therapeutic use
|
PL10 Other health care related causes of injury or harm
|
PL11 Mode of injury or harm associated with a surgical or other medical procedure
|
PL12 Mode of injury or harm associated with a surgical or other medical device, implant or graft
|
PL13 Mode of injury or harm associated with exposure to a drug, medicament or biological substance
|
PL13.0 Overdose of substance, as mode of injury or harm
|
PL13.1 Underdosing, as mode of injury or harm
|
PL13.2 Drug-related injury or harm in the context of correct administration or dosage, as mode of injury or harm
|
PL13.3 Incorrect substance, as mode of injury or harm
|
PL13.5 Incorrect administration of drug or medicament, as mode of injury
|
PL13.6 Medication or substance that is known to be an allergen, as mode of injury or harm
|
PL13.7 Medication or substance that is known to be contraindicated for the patient, as mode of injury or harm
|
PL13.8 Expired or deteriorated medication or substance, as mode of injury or harm
|
PL13.9 Drug or substance interactions, as mode of injury or harm
|
PL13.A Inappropriate stoppage or discontinuation of drug, as mode of injury or harm
|
PL13.Y Other specified mode of injury or harm associated with exposure to a drug, medicament or biological substance
|
PL13.Z Mode of injury or harm associated with exposure to a drug, medicament or biological substance, unspecified
|
PL14 Mode of injury or harm associated with other health care related causes
|
PL14.0 Non-administration of necessary drug
PL14.1 Non provision of necessary procedure
PL14.2 Problem associated with physical transfer of patient
PL14.3 Mismatched blood used in transfusion
PL14.4 Other problem associated with transfusion
PL14.5 Problem associated with physical restraints
PL14.6 Problem associated with isolation protocol
PL14.7 Problem associated with clinical documentation
PL14.8 Problem associated with clinical software
PL14.9 Incorrect diagnosis
PL14.A Delayed diagnosis
PL14.B Delayed treatment
PL14.C Patient received diagnostic test or treatment intended for another patient
PL14.D Problem associated with transitions of care, hand offs, or handovers
PL14.E Fall in health care
PL14.Y Other specified aspects of care associated with injury or harm
PL14.Z Mode of injury or harm associated with other health care related causes, unspecified
|
PL2Y Other specified external causes of morbidity or mortality
|
PL2Z External causes of morbidity or mortality, unspecified
|
|
24 Factors influencing health status or contact with health services
|
Reasons for contact with the health services
|
Contact with health services for purposes of examination or investigation
|
Contact with health services for counselling
|
QA10 Contact with health services for dietary counselling or surveillance
|
QA11 Contact with health services for alcohol use counselling or surveillance
|
QA12 Contact with health services for drug use counselling or surveillance
|
QA13 Contact with health services for tobacco use counselling
|
QA14 Contact with health services for human immunodeficiency virus counselling
|
QA15 Counselling related to sexuality
|
QA15.0 Counselling related to sexual attitudes
QA15.1 Counselling related to sexual behaviour or orientation or sexual relationships of the person
QA15.2 Counselling related to sexual behaviour or orientation or sexual relationships of third party
QA15.3 Counselling related to combined sexual attitudes, sexual behaviour or sexual relationships
QA15.Y Other specified counselling related to sexuality
QA15.Z Counselling related to sexuality, unspecified
|
QA16 Individual psychological or behavioural counselling
|
QA17 Marital or couples counselling
|
QA18 Family counselling
|
QA19 Group counselling
|
QA1A Discussion of issues surrounding impending death
|
QA1B Concern about or fear of medical treatment
|
QA1C Person with feared complaint in whom no diagnosis is made
|
QA1Y Contact with health services for other specified counselling
|
QA1Z Contact with health services for unspecified counselling
|
Contact with health services for reasons associated with reproduction
|
QA20 Contact with health services for concerns about pregnancy
|
QA21 Contact with health services for contraceptive management
|
Contact with health services for procreative management
|
QA40 Pregnancy examination or test
|
QA41 Pregnant state
|
QA42 Supervision of normal pregnancy
|
QA43 Supervision of high-risk pregnancy
|
QA44 Expectant parent pre-birth visit
|
QA45 Antenatal screening
|
QA46 Outcome of delivery
|
QA47 Liveborn infants according to place of birth
|
QA48 Postpartum care or examination
|
QA49 Problems related to unwanted pregnancy
|
QA4A Problems related to multiparity
|
QA4B Contact with health services for menopausal counselling
|
QA4Y Other specified contact with health services for reasons associated with reproduction
|
QA4Z Contact with health services for reasons associated with reproduction, unspecified
|
Health care related circumstances influencing the episode of care without injury or harm
|
Circumstances associated with a surgical or other medical procedure influencing the episode of care, without injury or harm
|
Circumstances associated with a surgical or other medical device influencing the episode of care without injury or harm
|
Circumstances associated with exposure to a drug, medicament or biological substance influencing the episode of care without injury or harm
|
Circumstances associated with other aspects of care influencing the episode of care without injury or harm
|
QB0Y Other specified health care related circumstances influencing the episode of care without injury or harm
|
QB0Z Health care related circumstances influencing the episode of care without injury or harm, unspecified
|
Factors related to medical facilities or other health care
|
QB10 Medical services not available in home
|
QB11 Person awaiting admission to adequate facility elsewhere
|
QB12 Waiting period for investigation or treatment other than awaiting admission to adequate facility elsewhere
|
QB13 Unavailability or inaccessibility of helping agencies other than health care facilities
|
QB14 Unavailability or inaccessibility of health care facilities
|
QB15 Medical services not available in current medical facility
|
QB16 Respite care
|
QB1Y Other specified factors related to medical facilities or other health care
|
QB1Z Factors related to medical facilities or other health care, unspecified
|
Donors of organs or tissues
|
Fitting, adjustment or management of devices
|
Dependence on enabling machines or devices
|
Presence of device, implants or grafts
|
Surgical or postsurgical states
|
Convalescence
|
Contact with health services for specific surgical interventions
|
QB80 Contact with health services for prophylactic surgery
|
QB80.0 Contact with health services for prophylactic surgery for risk-factors related to malignant neoplasms
QB80.Y Other specified contact with health services for prophylactic surgery
QB80.Z Contact with health services for prophylactic surgery, unspecified
|
QB81 Contact with health services for plastic surgery for unacceptable cosmetic appearance other than hair transplant
|
QB82 Contact with health services for routine or ritual circumcision
|
QB83 Follow-up care involving plastic surgery
|
QB84 Follow-up care involving removal of fracture plate or other internal fixation device
|
QB85 Attention to surgical dressings, drains or sutures
|
QB86 Contact with health services for hair transplant
|
QB8Y Contact with health services for other specified surgical interventions
|
QB8Z Contact with health services for specific surgical interventions, unspecified
|
Contact with health services for nonsurgical interventions not involving devices
|
Contact with health services for immunizations or certain other prophylactic measures
|
Interventions not carried out
|
Contact with health services for the health of others
|
QC30 Malingering
|
Personal or family history or late effect of prior health problems
|
Personal history of health problems
|
QC40 Personal history of malignant neoplasm
|
QC40.0 Personal history of malignant neoplasm of digestive organs
QC40.1 Personal history of malignant neoplasm of trachea, bronchus or lung
QC40.2 Personal history of malignant neoplasm of respiratory or intrathoracic organs other than the digestive organs, trachea, bronchus or lung
QC40.3 Personal history of malignant neoplasm of breast
QC40.4 Personal history of malignant neoplasm of genital organs
QC40.5 Personal history of malignant neoplasm of urinary tract
QC40.6 Personal history of leukaemia
QC40.7 Personal history of other malignant neoplasms of lymphoid, haematopoietic or related tissues
QC40.Y Personal history of malignant neoplasm of other specified site
QC40.Z Personal history of malignant neoplasm of unspecified site
|
QC41 Personal history of non-malignant neoplasms
|
QC42 Personal history of infectious or parasitic diseases
|
QC43 Personal history of diseases of the blood or blood-forming organs
|
QC44 Personal history of diseases of the immune system
|
QC45 Personal history of endocrine, nutritional or metabolic diseases
|
QC46 Personal history of mental or behavioural disorder
|
QC47 Personal history of diseases of the nervous system or sense organs
|
QC48 Personal history of medical treatment
|
QC49 Personal history of noncompliance with medical treatment or regimen
|
QC4A Personal history of poor personal hygiene
|
QC4B Personal history of self-harm
|
QC4Y Personal history of other specified health problems
|
QC4Z Personal history of health problems, unspecified
|
QC50 Late effect of prior health problem, not elsewhere classified
|
Family history of health problems
|
QC60 Family history of infectious diseases
|
QC61 Family history of malignant neoplasm
|
QC61.0 Family history of malignant neoplasm of digestive organs
QC61.1 Family history of malignant neoplasm of trachea, bronchus or lung
QC61.2 Family history of malignant neoplasm of respiratory or intrathoracic organs other than digestive organs, trachea, bronchus or lung
QC61.3 Family history of malignant neoplasm of breast
QC61.4 Family history of malignant neoplasm of genital organs
QC61.5 Family history of malignant neoplasm of urinary tract
QC61.6 Family history of leukaemia
QC61.7 Family history of malignant neoplasms of lymphoid, haematopoietic or related tissues
QC61.Y Other specified family history of malignant neoplasm
QC61.Z Family history of malignant neoplasm, unspecified
|
QC62 Family history of diseases of the blood or blood-forming organs
|
QC63 Family history of disorders involving the immune mechanism
|
QC64 Family history of endocrine, nutritional or metabolic diseases
|
QC65 Family history of mental or behavioural disorder
|
QC66 Family history of eye or ear disorders
|
QC67 Family history of ischaemic heart disease or other diseases of the circulatory system
|
QC68 Family history of consanguinity
|
QC69 Family history of stroke
|
QC6Y Family history of other specified health problems
|
QC6Z Family history of health problems, unspecified
|
QC8Y Other specified personal or family history or late effect of prior health problems
|
QC8Z Personal or family history or late effect of prior health problems, unspecified
|
Risk factors associated with infectious or certain other conditions
|
Concern about body appearance
|
QD30 Concern about breast appearance
QD31 Contact with health services for concerns about body image related to pregnancy
QD3Y Other specified concern about body appearance
QD3Z Concern about body appearance, unspecified
|
Factors influencing health status
|
Problems associated with finances
|
Problems associated with drinking water or nutrition
|
Problems associated with the environment
|
QD70 Problems associated with the natural environment or human-made changes to the environment
|
QD71 Problems associated with housing
|
QD71.0 Homelessness
QD71.1 Inadequate housing
QD71.2 Problems related to living in residential institution
QD71.Z Problems associated with housing, unspecified
|
QD7Y Other specified problems associated with the environment
|
QD7Z Problems associated with the environment, unspecified
|
Problems associated with employment or unemployment
|
Problems associated with education
|
Problems associated with social or cultural environment
|
Problems associated with health behaviours
|
Hazardous substance use
|
QE10 Hazardous alcohol use
|
QE11 Hazardous drug use
|
QE11.0 Hazardous use of opioids
QE11.1 Hazardous use of cannabis
QE11.2 Hazardous use of sedatives, hypnotics or anxiolytics
QE11.3 Hazardous use of cocaine
QE11.4 Hazardous use of stimulants including amphetamines or methamphetamine
QE11.5 Hazardous use of caffeine
QE11.6 Hazardous use of MDMA or related drugs
QE11.7 Hazardous use of dissociative drugs including ketamine or PCP
QE11.8 Hazardous use of other specified psychoactive substances
QE11.9 Hazardous use of unknown or unspecified psychoactive substances
QE11.Y Other specified hazardous drug use
QE11.Z Hazardous drug use, unspecified
|
QE12 Hazardous nicotine use
|
QE13 Tobacco use
|
QE1Y Other specified hazardous substance use
|
QE1Z Hazardous substance use, unspecified
|
QE20 Lack of physical exercise
|
QE21 Hazardous gambling or betting
|
QE22 Hazardous gaming
|
QE23 Problems with inappropriate diet or eating habits
|
QE24 Problems with hygiene behaviours
|
QE25 Problems with oral health behaviours
|
QE26 Problem with sun exposure behaviour
|
QE27 Problem with behaviours related to psychological health or wellbeing
|
QE28 Problem with health literacy
|
QE2Y Problems with other specified health-related behaviours
|
QE2Z Problem with health-related behaviours, unspecified
|
Problems associated with social insurance or welfare
|
Problems associated with the justice system
|
Problems associated with relationships
|
QE50 Problem associated with interpersonal interactions
|
QE50.0 Problem associated with relationship with friend
|
QE50.1 Relationships with teachers or classmates
|
QE50.10 Dissatisfaction with school environment
QE50.1Y Other specified relationships with teachers or classmates
QE50.1Z Relationships with teachers or classmates, unspecified
|
QE50.2 Problem associated with relationships with people at work
|
QE50.3 Relationships with neighbours, tenant or landlord
|
QE50.4 Relationship with parents, in-laws or other family members
|
QE50.5 Discord with counsellors
|
QE50.6 Inadequate social skills
|
QE50.7 Personality difficulty
|
QE50.Y Other specified problem associated with interpersonal interactions
|
QE51 Problem associated with interactions with spouse or partner
|
QE51.0 Relationship distress with spouse or partner
QE51.1 History of spouse or partner violence
QE51.Y Other specified problem associated with interactions with spouse or partner
QE51.Z Problem associated with interactions with spouse or partner, unspecified
|
QE52 Problem associated with interpersonal interactions in childhood
|
QE52.0 Caregiver-child relationship problem
QE52.1 Loss of love relationship in childhood
QE52.Y Other specified problem associated with interpersonal interactions in childhood
QE52.Z Problem associated with interpersonal interactions in childhood, unspecified
|
QE5Y Other specified problems associated with relationships
|
QE5Z Problems associated with relationships, unspecified
|
Problems associated with absence, loss or death of others
|
QE70 Problems related to primary support group, including family circumstances
|
QE70.0 Inadequate family support
QE70.1 Disruption of family by separation or divorce
QE70.2 Dependent relative needing care at home
QE70.Z Problems related to primary support group, including family circumstances, unspecified
|
Problems associated with harmful or traumatic events
|
Problems associated with upbringing
|
QE90 Inadequate parental supervision or control
QE91 Parental overprotection
QE92 Altered pattern of family relationships in childhood
QE93 Removal from home in childhood
QE94 Institutional upbringing
QE95 Inappropriate parental pressure or other abnormal qualities of upbringing
QE96 Events resulting in loss of self-esteem in childhood
QE9Y Other specified problems associated with upbringing
QE9Z Problems associated with upbringing, unspecified
|
Acquired absence of body structure
|
QF10 Limited function or disability of body organ or system
|
Difficulty or need for assistance with activities
|
QF20 Difficulty or need for assistance with learning
QF21 Difficulty or need for assistance with general life tasks or life management
QF22 Difficulty or need for assistance with communication
QF23 Difficulty or need for assistance with mobility
QF24 Difficulty or need for assistance with self-care
QF25 Difficulty or need for assistance with relationships
QF26 Difficulty or need for assistance with household tasks
QF27 Difficulty or need for assistance at home and no other household member able to render care
QF28 Difficulty or need for assistance with work activities
QF29 Difficulty or need for assistance with major areas of life
QF2A Difficulty or need for assistance with community participation
QF2B Need for continuous supervision
QF2Y Difficulty or need for assistance with other specified activity
QF2Z Difficulty or need for assistance with unspecified activity
|
QF4Y Other specified factors influencing health status or contact with health services
|
QF4Z Factors influencing health status or contact with health services, unspecified
|
|
25 Codes for special purposes
|
International provisional assignment of new diseases of uncertain aetiology and emergency use
|
RA00 Conditions of uncertain aetiology and emergency use
|
RA00.0 Vaping related disorder
|
RA01 COVID-19
|
RA02 Post COVID-19 condition
|
RA03 Multisystem inflammatory syndrome associated with COVID-19
|
RA04 International emergency code 05
|
RA05 International emergency code 06
|
RA06 International emergency code 07
|
RA07 International emergency code 08
|
RA08 International emergency code 09
|
RA09 International emergency code 10
|
National provisional assignment of new diseases of uncertain aetiology
|
|
26 Supplementary Chapter Traditional Medicine Conditions
|
Module I
|
Module II
|
Traditional medicine disorders (TM2)
|
Head, brain, nerve and movement disorders (TM2)
|
Eye, ear, nose, throat and neck disorders (TM2)
|
Respiratory system disorders (TM2)
|
Heart, blood and circulatory disorders (TM2)
|
Heart disorders (TM2)
|
Circulatory disorders (TM2)
|
Blood related disorders (TM2)
|
SL80 Anaemia disorder (TM2)
SL81 Bleeding disorder disorder (TM2)
SL8Y Other specified blood related disorders (TM2)
SL8Z Blood related disorders (TM2), unspecified
|
SM00 Lymphadenopathy disorder (TM2)
|
SM01 Elephantiasis disorder (TM2)
|
SM0Y Other specified heart, blood and circulatory disorders (TM2)
|
SM0Z Heart, blood and circulatory disorders (TM2), unspecified
|
Gastro-intestinal disorders (TM2)
|
Urinary and reproductive system disorders (TM2)
|
Urinary system disorders (TM2)
|
Female Reproductive System disorders (TM2)
|
Male Reproductive System disorders (TM2)
|
Pregnancy and childbirth related disorders (TM2)
|
SN10 Decreased breastmilk disorder (TM2)
SN11 Vitiated breast milk disorder (TM2)
SN12 Recurrent pregnancy loss disorder (TM2)
SN1Y Other specified pregnancy and childbirth related disorders (TM2)
SN1Z Pregnancy and childbirth related disorders (TM2), unspecified
|
SN30 Gonorrhoea disorder (TM2)
|
SN31 Syphillis disorder (TM2)
|
SN3Y Other specified urinary and reproductive system disorders (TM2)
|
SN3Z Urinary and reproductive system disorders (TM2), unspecified
|
Skin, nail and hair disorders (TM2)
|
Bone, joint and muscle disorders (TM2)
|
Disorders affecting the whole body (TM2)
|
Mental, emotional and behavioural disorders (TM2)
|
External factors disorders (TM2)
|
Childhood disorders (TM2)
|
Traditional medicine patterns (TM2)
|
Functional elements and humoral derangement patterns (TM2)
|
Physical constituent derangement patterns (TM2)
|
SR40 Vitiation of 'primary structural components of the body' pattern (TM2)
|
SR41 Aggravation of primary circulating nutrient fluid pattern (TM2)
|
SR42 Depletion of primary circulating nutrient fluid pattern (TM2)
|
SR43 Morbid increase of blood pattern (TM2)
|
SR44 Depletion of blood pattern (TM2)
|
SR45 Excessive increase of muscular tissues pattern (TM2)
|
SR46 Depletion of muscular tissues pattern (TM2)
|
SR47 Increase of adipose tissues pattern (TM2)
|
SR48 Depletion of adipose tissues pattern (TM2)
|
SR49 Increase of bone tissues pattern (TM2)
|
SR4A Depletion of bone tissues pattern (TM2)
|
SR4B Increase of bone marrow pattern (TM2)
|
SR4C Depletion of bone marrow pattern (TM2)
|
SR4D Increase of reproductive tissues and semen pattern (TM2)
|
SR4E Depletion of reproductive tissues and semen pattern (TM2)
|
SR4F Diminution of Ojas pattern (TM2)
|
SR4G Derangement of Ojas pattern (TM2)
|
SR4H Dislodgement of Ojas pattern (TM2)
|
SR4J Increased menstrual flow pattern (TM2)
|
SR4K Diminution of menstrual flow pattern (TM2)
|
SR4L Increased secretion of breast milk pattern (TM2)
|
SR4M Decreased secretion of breast milk pattern (TM2)
|
Derangement of channels pattern (TM2)
|
SR50 Derangement of channels carrying essense of digested food pattern (TM2)
SR51 Derangement of channels enriching blood pattern (TM2)
SR52 Derangement of channels enriching muscle tissue pattern (TM2)
SR53 Derangement of channels carrying fat pattern (TM2)
SR54 Derangement of channels enriching bone pattern (TM2)
SR55 Derangement of channels enriching bone marrow pattern (TM2)
SR56 Derangement of channels enriching seminal fluid pattern (TM2)
SR57 Derangement of channels enriching vital life force pattern (TM2)
SR58 Derangement of channels for fluid circulation pattern (TM2)
SR59 Derangement of digestive tract pattern (TM2)
SR5A Derangement of channels of faeces pattern (TM2)
SR5B Derangement of urinary tract pattern (TM2)
SR5C Derangement of channels producing sweat pattern (TM2)
SR5D Derangement of channels enriching breast milk pattern (TM2)
SR5E Derangement of mind related channels pattern (TM2)
SR5Y Other specified derangement of channels pattern (TM2)
SR5Z Derangement of channels pattern (TM2), unspecified
|
SR60 Increase of female reproductive tissue pattern (TM2)
|
SR61 Decrease of female reproductive tissue pattern (TM2)
|
SR62 Pattern resulting in abnormal number of organs and appendages (TM2)
|
SR63 Pattern of abnormal positioning of organs and appendages (TM2)
|
SR64 Pattern of abnormal relative position of organs (TM2)
|
SR65 Loss of continuity pattern (TM2)
|
SR66 Rīḥ pattern (TM2)
|
SR67 Bukhārāt pattern (TM2)
|
SR68 Compound pattern (TM2)
|
SR69 Pattern of quantity (TM2)
|
SR6Y Other specified physical constituent derangement patterns (TM2)
|
SR6Z Physical constituent derangement patterns (TM2), unspecified
|
Excretory products derangement patterns (TM2)
|
Power derangement and chronic accumulation patterns (TM2)
|
Body constitution and temperament patterns (TM2)
|
Varmam and Marmam patterns (TM2)
|
|
27 Supplementary section for functioning assessment
|
WHODAS 2.0 36-item version
|
Cognition [WHODAS]
|
Mobility [WHODAS]
|
Self-care [WHODAS]
|
Getting along [WHODAS]
|
VD30 Relating with strangers [WHODAS]
VD31 Informal relationship with friends maintaining [WHODAS]
VD32 Family relationships [WHODAS]
VD33 Informal relationship with friends making new friends [WHODAS]
VD34 Intimate relationships [WHODAS]
|
Life activities [WHODAS]
|
Participation and impact of health problems [WHODAS]
|
VD50 Recreation and leisure [WHODAS]
VD51 Problems by barriers [WHODAS]
VD52 Human rights [WHODAS]
VD53 Time spent on health condition [WHODAS]
VD54 Emotional effect of health condition [WHODAS]
VD55 Health drain on financial resources [WHODAS]
VD56 Health problems causing family problems [WHODAS]
VD57 Problems in relaxation or pleasure [WHODAS]
|
Brief Model Disability Survey
|
VE00 Seeing and related functions [BMDS]
|
VE01 Hearing and vestibular functions [BMDS]
|
Mental functions [BMDS]
|
Sensory functions and pain [BMDS]
|
Generic functioning domains
|
Mental functions
|
Sensory functions and pain
|
VV10 Seeing and related functions
VV11 Hearing and vestibular functions
VV12 Sensation of pain
VV1Y Other specified sensory functions and pain
VV1Z Sensory functions and pain, unspecified
|
Voice and speech functions
|
Functions of the cardiovascular, haematological, immunological and respiratory systems
|
Functions of the digestive, metabolic and endocrine systems
|
VV40 Functions related to the digestive system
VV4Y Other specified functions of the digestive, metabolic and endocrine systems
VV4Z Functions of the digestive, metabolic and endocrine systems, unspecified
|
Genitourinary and reproductive functions
|
Neuromusculoskeletal and movement-related functions
|
VV60 Mobility of joint functions
VV61 Muscle power functions
VV6Y Other specified neuromusculoskeletal and movement-related functions
VV6Z Neuromusculoskeletal and movement-related functions, unspecified
|
Functions of the skin and related structures
|
VV70 Functions of the skin
VV7Y Other specified functions of the skin and related structures
VV7Z Functions of the skin and related structures, unspecified
|
Learning and applying knowledge
|
General tasks and demands
|
Communication
|
Mobility
|
Self-care
|
Domestic life
|
Interpersonal interactions and relationships
|
VW40 Basic interpersonal interactions
VW41 Relating with strangers
VW42 Intimate relationships
VW4Y Other specified interpersonal interactions and relationships
VW4Z Interpersonal interactions and relationships, unspecified
|
Major life areas
|
Community, social and civic life
|
VW8Y Other specified generic functioning domains
|
VW8Z Generic functioning domains, unspecified
|
ICD-11 International Classification of Diseases